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Abstract 
The pharmacy profession has an ethical and professional obligation to ensure that 
pharmacists can discharge their duties with skill and safety and to protect patients and the 
profession’s reputation as caregivers.  
Impairment of a healthcare professional (HCP) is the inability to practice according to 
accepted standards of practice due to mental or physical disability, condition or disorder. A 
significant 10% to 15% of pharmacists misuse substances in their careers. Substance abuse 
is a disease that is amenable to treatment. There is a moral and professional obligation to 
assist impaired colleagues get access to this treatment. Gaps in the literature exist, 
suggesting that pharmacist impairment is an under-researched area. 
There is one available support program for pharmacists in Australia, the Pharmacist 
Support Service (PSS) centred in Victoria. Little is known about this service and whether it 
is addressing the issue of impairment. This exploratory study investigates the PSS 
program, its scope of assistance, the nature of its services in the profession, and its role in 
addressing impairment. 
Hard copies of a confidential, non-validated, explorative survey with self-addressed 
envelopes, were mailed to the 19 PSS volunteers. Semi-structured interviews with 10 
volunteers were audiotape-recorded with the permission of the volunteers. Verbatim 
transcripts were made of the discussions and the data entered into NVIVO. Data analysis 
commenced during and continued throughout the data collection process. Categories were 
inductively obtained. All data relevant to each category were identified and examined 
using constant comparison. 
Findings highlighted the need for support for pharmacists. Volunteers’ insight into the 
scope of assistance they offer to callers, sometimes lifesaving support, emphasised the 
need for an international support program specifically for pharmacists. The need to address 
pharmacist stress and issues was seen as necessary to provide optimal service and the 
prevention of error in a profession that has no room for error. 
Some concerning limitations on the efficacy of the PSS program were identified. The 
necessary adherence to privacy laws meant that follow-up was sometimes impossible. 
Limited training in dealing with impairment and requiring ongoing support were identified. 
Concerns about a lack of awareness of PSS in the profession were raised as a possible 
explanation for the small number of calls received.  
	   v	  
The need to better address pharmacist impairment in Australia emerged as an important 
issue. PSS had both financial limitations and lack of availability of expertise to prevent the 
program from comprehensively addressing the issue. Its role in addressing impairment is 
predominantly a listening ear and referral service. Impairment is being addressed 
internationally using prevention, treatment and rehabilitation programs. These adopt a non-
punitive medical model approach which encourages early identification. Treatment 
programs based on the six step rehabilitation philosophy report high success rates of up to 
85% for reentry into practice. The pharmacy profession in Australia does not enjoy the 
effective programs based on overseas models that are available to Australian doctors and 
nurses. This may be due to the smaller number of pharmacists in Australia which may be 
an impediment to the formation and sustainability of a impaired pharmacist program. Calls 
for an integrated program for all impaired health care professionals were made to improve 
viability for the different professions. 
Early identification would be a prime concern for such a program. PSS volunteers called 
for better transparency as a potential means for lifting barriers to reporting impairment. 
Clear and relevant information stating exactly the procedure taken by AHPRA officials 
once reporting occurs is necessary to dispel the fear associated with reporting. More 
information and education about the issue is also necessary to dispel the stigma associated 
with impairment in order to facilitate timely reporting, treatment and reentry to the 
workforce. 
Additionally, key concerns surfaced regarding the mandatory reporting requirements. 
Ironically, mandatory reporting may actually impede the reporting of impairment. 
Volunteers revealed a hesitancy to refer impaired callers to professional help as they were 
unable to reassure callers that they would not be reported when they tried to access this 
assistance. Volunteers were not able to offer their confidential assistance if they were 
registered due to their obligation to report and utilised several measures to evade the issue. 
These measures included; requesting a retired unregistered volunteer to assist at a later 
time and promoting anonymity. 
The findings provide an insight into Australia’s impaired pharmacist population that has 
been the subject of very limited research. The provision of an integrated support program 
is required that comprehensively addresses the issue to minimise the serious social and 
professional implications associated with impairment. 
  
	   vi	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CHAPTER ONE   
SUPPORT SERVICES FOR AUSTRALIAN PHARMACISTS 
 
1 Introduction 
Performance concerns are a key issue for those who regulate healthcare professionals 
(HCPs) around the world. Impairment of a HCP is the inability to practice according to 
accepted standards of practice due to mental or physical disability, condition or disorder. 
(1, 2) Impairment of a healthcare professional is most commonly due to substance use 
disorder (abuse or dependence) and mental illness. (3) Substance use disorder has 
historically been viewed as a moral weakness, then as a social problem affecting the lower 
socioeconomic class, and then determined to be a criminal problem. (4) However it is 
currently defined using the medical model approach as a multifaceted condition whose 
etiology includes factors related to genetics, neurobiological markers, gender, and 
sociocultural and psychosocial issues. (5-7)  
This section reviews the available data on pharmacist impairment and determines 
Australia’s relative position in approaching the issue in terms of prevalence, contributing 
factors, treatment options and re-entry into clinical practice. 
 
1.1 Incidence of impairment 
The term “impairment” has a specific meaning as defined by AHPRA under the Australian 
National Law (Health Practitioner Regulation National Law Act). It refers to a physical or 
mental impairment, disability, condition or disorder (including substance 
abuse/dependence) that is linked to a practitioner’s capacity to practise or a student’s 
capacity to undertake clinical training. (8) 
Mental illness and substance abuse are the most common forms of impairment in HCPs. 
(3) Mental illness is common in Australia, a 2007 study finding that one in five Australians 
experiencing a mental illness in any 12 month period. This study categorized substance use 
disorder as a mental illness. Anxiety disorders affected 14% of Australians, affective 
disorders (such as depression) affected 6%, while substance use disorders accounted for 
5%. One in two Australians experienced a mental illness during their lifetime. (9) 
Impairment due to mental illness without concurrent substance dependency accounted for 
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between 6%-20% of cases reported to state physician health programs in the US in 1982. 
(10) No peer-reviewed study was found that explored the prevalence or impact of mental 
illness or cognitive impairment on pharmacist performance. This is an under-researched 
domain, given that the burden of disease and injury (in a 2003 study) indicated that mental 
disorders constitute the leading cause of disability burden in Australia, accounting for an 
estimated 24% of the total years lost due to disability. (11) 
 
In a study of a cohort of 261 medical registrants referred to the NSW Board because of 
impairment between l981 and 2001, 40% had a ‘primary impairment’ of mental illness, 
56% drug and alcohol abuse, and 4% physical illness. (12) Comorbidity was unreported in 
this study, but there are strong links between substance abuse and other mental illnesses. 
The prevalence of comorbid alcohol, other drug, and mental disorders in the population of 
the United States of America (US) was determined from 20,291 persons interviewed in the 
National Institute of Mental Health Epidemiologic Catchment Area Program in 1990. 
Among those with a mental disorder, 29% also abused drugs or alcohol in their lifetime. 
Among those with an alcohol disorder, 37% had a comorbid mental disorder. The highest 
mental-addictive disorder comorbidity rate was found for those with drug (other than 
alcohol) disorders, among whom more than half (53%) were found to have a mental 
disorder. (13)  
 
In Australia, there was a significant increase between 2007 and 2010 in the percentage of 
the general population that reported using an illicit drug in the previous 12 months, from 
13.4% to 14.7%. (14) The abuse of methadone/buprenorphine (non-maintenance use), 
painkillers/analgesics, tranquillisers/sleeping pills and other opiates all increased in this 
interval. (14) These medications were all easily accessible to pharmacists. With societal 
substance use and abuse on the rise, impairment of HCPs may become a more pressing 
issue in the future. 
 
There is a critical need for more current prevalence data on substance abuse in healthcare 
professionals. There is limited research in the last decade (15) and even less data has been 
published on the prevalence of substance abuse among Australian HCPs. (16) Whilst there 
is no study to date examining the prevalence of impairment in the profession of pharmacy 
in Australia, based on reports in the international literature the prevalence of chemical 
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dependency is estimated at 10% to 15% of all HCPs, similar to that of the general 
population. (17) However, HCP rates of use (i.e., not meeting the criteria for abuse or 
dependence) of substances, in particular of opiates and benzodiazepines, has been reported 
as five times higher than the general public in studies of doctors. (18-20) 
 
Published data on substance misuse in pharmacists is largely limited to an older small body 
of self-reported studies on alcohol and drug use, the majority published in the US. (21) 
Pharmacists in the US reported higher rates of past-month use of minor opiates and 
anxiolytics than the general population. Kenna et al in 2004 described occasional use of 
opiates and anxiolytics by pharmacists as “fairly substantial.” Non-authorised minor 
lifetime opiate use by pharmacists was found to be greater than for other HCPs. (15) US 
pharmacists reported higher levels of heavy episodic alcohol use (12%) than all other 
health professionals except dentists (16%) with older HCPs drinking significantly more 
than younger peers. (22) 
 
Self-medicating without a prescription is a significant issue in the pharmacy profession. 
Nearly 40% of pharmacists in a US self-report mailed survey study in 2002 by Dabney et 
al indicated they had used a form of potentially addictive prescription drug (PAPD) 
without first obtaining a physician’s prescription. Of these, 69% directly violated the law 
and their professional code of ethics by stealing PAPDs from their place of employment or 
forging prescriptions. Almost 6% of respondents identified themselves as being substance 
abusers at some point during their pharmacy careers. (23) An older New England study in 
1987 McAuliffe et al found that 46% of the pharmacists and 62% of the pharmacy students 
reported having used a controlled substance at some time without a prescription. (24)  
 
The only recent study that compared its findings about pharmacy students with national 
data for all students and the general population, was conducted in the US by Kenna et al in 
2004. (15) While pharmacy students were found to use drugs most often for recreation, use 
by pharmacists was more equally divided into self-treatment, recreation and exploration 
purposes. The drugs most often used were marijuana, stimulants, tranquillisers, and 
opiates. Substance use was generally limited in amount. However 18% of the pharmacists 
and 35% of the pharmacy students who had ever used a drug either became dependent or 
were at risk of substance abuse. (15)  
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Few studies explored cross healthcare group comparisons. Kenna et al’s 2004 self-reported 
survey study comparing 748 HCPs in the US, revealed rates of total illicit drug use by 
pharmacists were similar to those of dentists, nurses and physicians. Past-year prevalence 
of drug use was highest among pharmacists at 12.8%. (15) A greater proportion of 
pharmacists also reported lifetime use of minor opiates, anxiolytics, stimulants and 
marijuana as their most frequently used illicit drug. (15) Pharmacists in the study had a 
higher rate of using oral stimulants, but reportedly used less parenteral drugs than other 
HCPs. (3)  
 
No recent comparative HCP study into drinking habits was found. A 1991 study by 
McAuliffe et al comparing HCPs drinking habits revealed that pharmacists and pharmacy 
students were more likely to be abstainers (10%) compared to physicians and medical 
students (6%). (25) While medical students consumed alcohol more frequently than 
pharmacy students, pharmacy students reported consuming greater quantities per drinking 
episode. (25) Kenna et al 2004 more recently revealed that 10% of pharmacists studied 
worried that they were consuming too much alcohol. (22) 
 
Prevalence data for substance abuse in Australian pharmacists is lacking and thus cannot 
be compared with international data. However prevalence data on Australian doctors is 
congruent with international data. The Medical Board of California estimated that 18% of 
physicians in the state abuse alcohol or other drugs during their lifetime and 2% should be 
in treatment at any one time. (26) Rates of sanctioned and treated physicians from US state 
licensing programs varied between 1% and 3%. (10) Australian data on physicians seems 
congruent with these US statistics. (16) A retrospective review revealed 0.4% of 1994 
NSW doctors had their drug authorities withdrawn as a result of confirmed opioid self-
administration. (16) Two studies by Serry et al of Victorian doctors with serious drug 
dependency indicated a prevalence of about 0.5%. (27, 28) In a 1995 survey in NSW, 1% 
of doctors surveyed reported drug abuse problems, a figure close to estimates from other 
countries. (29)  
 
1.2 Implications of impairment 
Although the rates of substance use disorder in HCPs are considered similar to those of the 
general population (excluding nicotine), this is a major concern to society, which entrusts 
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its welfare and safety to those in the health professions. (3) Substance use disorder is a 
public health problem with significant economic and social implications. It affects work 
ethic and potentially results in errors.  
 
A 1994 study by Kenna et al revealed 12% of pharmacists studied had called in sick or late 
due to alcohol consumption. Significantly, 21% of pharmacists reported that drinking had 
caused them at least one minor dysfunction and 10% reported it caused one or more major 
dysfunction. An overall 24% of pharmacists had some alcohol related dysfunction, with 
3% concerned that drinking had led them to provide suboptimal patient care. (22) In a 
more recent 2004 study by Kenna et al, 3% of pharmacists reported that their use of drugs 
(other than alcohol) had caused them one or more minor dysfunctions, 2% reported that it 
had caused them one or more major dysfunction. (15) Medication errors caused by 
substance-impaired pharmacists have been cited as posing a direct and serious threat to the 
public (30) and are thus of concern to the pharmacy profession. 
 
1.3  Reasons to intervene 
The pharmacy profession has an ethical and professional obligation to ensure that 
pharmacists can discharge their duties with skill and safety, and to protect patients and the 
profession’s reputation as caregivers. (3, 26, 31) However the pharmacy profession also 
has an obligation towards its members to assist them with their condition and their careers. 
If not identified and treated, the impaired pharmacist is likely to experience loss of 
registration and career, destruction of family and personal life, and even death through 
overdose, suicide, or other complications of the condition. (26)  
 
While the welfare of patients is the reason for the existence of impairment programs, most 
professionals also agree that restoring them to good personal and professional health are 
equally important. (10) In a 1998 NSW study, 13% of the studied doctors who had their 
drug authorities withdrawn as a result of confirmed opioid self-administration, died in the 
study period 1985-1994. (16) Besides the high mortality rate, a substantial number never 
returned to practice. (16) Each year in the US 100 deaths among physicians are directly 
attributable to substance abuse. (10) Bissell at al in 1989 interviewed 86 pharmacists 
recovering from substance abuse and revealed the following figures: 44 had been arrested; 
45 had experienced unemployment; 16 lost their registrations. 18 reported suicide attempts, 
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13 of these by drug overdose. (32) 
 
There were other reported losses associated with HCPs unable to re-enter the workforce, 
such as; wasted training, financial losses due to staff turnover and loss of contribution to 
the profession. (33) There was an overall loss from the medical profession in NSW of 34% 
of the doctors who had their drug authorities withdrawn as a result of confirmed self-
administration of opioids. (16) Impaired professionals have made major contributions to 
health care, as seen from the life of William S. Halstead (1852-1922), the father of modern 
surgery. Halstead’s addiction resulted from his self-experimentation using cocaine as a 
surgical anesthetic. His accomplishments highlight the need to assist impaired colleagues 
not only on a personal level but also because of their potential for contributions to society. 
(34) An understanding of the contributing factors of this condition is required to provide 
this required assistance. 
 
1.4 Contributing Factors  
There are several risk factors that may predispose pharmacists to initiate and continue an 
addiction, one of which is access to drugs. Whilst pharmacy students reported daily 
cigarette use much less frequently than other college students, they were more likely to use 
medications that are accessible, such as opiates and anxiolytics. (30) Only 15% of 
pharmacy students studied by McAuliffe et al in a 1987 study with difficult or very 
difficult access to drugs used those drugs, compared with 48% of pharmacy students who 
had easy or very easy access to drugs through some means. (24)  
 
A stressful work setting, overwork and fatigue have also been identified as predisposing 
factors of impairment in HCPs. (35) Workplace stress may be a risk factor for developing 
psychological or emotional impairment. Healthcare professionals may have underlying 
personality, mood, or behavioral disorders or mental illnesses that may be unmasked by the 
stress of their occupational and social and personal obligations. (3)  
 
A number of cultural factors have been found to affect the likelihood of substance use. A 
family history of drug or alcohol use also has a strong correlation with drug abuse. In an 
ongoing US prospective study, Moore (1990) found that those that participated in religious 
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practices were less likely to be substance abusers. (36) Similarly, McAuliffe et al (1987) in 
the US found the highest rates of drug use were reported among nonreligious HCPs. (24) 
 
Cigarette use has been shown to be a strong correlate of heavy drinking. Both cigarettes 
and alcohol were found to be important predictors of substance abuse in several studies of 
HCPs. (31, 36)  
 
Self-medicating to treat physical or mental symptoms was another reportedly significant 
risk factor. (24, 35) It was found in McAuliffe et al’s 1987 US study that there was a 
strong tendency for healthcare professionals to self-diagnose and treat themselves without 
seeking the help of colleagues. (3, 24) Tolerant attitudes to self-medication without 
prescription within the pharmacy profession were a chief contributing factor in pharmacist 
initial use and subsequent abuse of prescription drugs in the US in 2004 as found by Kenna 
et al. (30) Only 53% of pharmacists in this study believed that self-medicating was not to 
be tolerated under any circumstances.  
Pharmacists who self-medicated reported being unable or unwilling to distinguish between 
the danger of a so-called “harmless drug” such as an antibiotic, to the potentially addictive 
drugs. A pro self-medicating norm in pharmacy subculture was clearly identified in this 
study. (30) Furthermore, research has found that a strong belief in personal immunity to 
becoming addicted to drugs, due to superior drug knowledge of HCPs, may increase the 
likelihood of addiction. (3, 31) 
 
A personal history of illicit drug use was also found to be a predictor of future abuse. (37) 
For example, a 2001 survey by Dabney in the US found that 88% of pharmacists who 
reported abusing a potentially addictive prescription drug, did so first whilst at college. 
(38) This is consistent with the prevalence of substance use reportedly declining with age 
after peaking in young adulthood. (31) Older HCPs were less likely to report using 
significant levels of drug use as found by Kenna et al in a 2008 US study. Knowing that 
younger HCPs are at the highest risk suggested that professional licensing boards have an 
opportunity to broach the subject of non-prescribed drug use with newly licensed HCPs. 
(31) 
 
The very traits which make physicians successful may also predispose them to impairment. 
Many physicians reportedly have a strong drive to achieve and excel at work and may deny 
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personal and social problems. (26) These traits are often shared by pharmacists. (32) Risk 
factors such as idealistic beliefs, perfectionist behavior, and high academic rank in the 
class, correlated with drug use in physicians or medical students in several studies. (39, 40) 
Impaired pharmacists were found to be above average students, adept practitioners, and 
generally upstanding members of their communities in a 1989 study by Bissell et al in the 
US. (32) These personality characteristics and those of competitiveness, obsessiveness, and 
a tendency to isolate under stress, have been identified in depressed physicians and are 
predisposing factors. (3)  
 
1.5 Presentation and Diagnosis  
Impaired HCPs can be difficult to identify because they can be adept at hiding signs and 
symptoms of substance abuse. (3) Initial problems usually affect relationships with family 
and friends. (3) Problems with personal relations manifest as marital or interpersonal strife, 
or demonstrations of increasingly variable and inconsistent behavior toward others. (26)  
 
Problems at home reportedly manifest as withdrawal from family members and friends, an 
increase in the number of accidents, an increase in medical problems, financial difficulties, 
and lack of responsibility for personal, family, and community obligations. (41)  
 
Changes in work habits include absence from work, late arrival, missed appointments and 
inappropriate behavior or conflicts with colleagues, staff and patients. (3) Some warning 
signs of substance abuse that are specific to HCPs include; inaccessibility to patients and 
staff, frequent absences, large quantities of drugs ordered, forgotten verbal orders, slurred 
speech during off-hours for phone calls for orders and heavy drinking at staff functions. 
(42)  
 
1.6 Identification and Reporting 
The hallmark of substance dependency is denial. (26) It is therefore unreasonable to wait 
for spontaneous insight from the afflicted pharmacist. Many international HCP Boards 
have recognised the ethical obligation to report impairment. The American Medical 
Association (AMA), the Charter on Medical Professionalism, and the European Federation 
of Internal Medicine state that physicians have an “ethical obligation to report” and are 
expected to “participate in the process of self-regulation. (43-45) Many pharmacy 
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regulatory bodies go further, enforcing mandatory reporting statutes that require HCPs to 
report to appropriate authorities those HCPs whose ability to practice is impaired by 
substance abuse or by physical or mental illness. Most US State Pharmacy Boards have 
mandatory reporting requirements. (43) The Pharmacy Board of Australia recently 
legislated that the reporting of an impaired health-carer/colleague is mandatory in Australia 
(July 2010). (8) It is anticipated that there will be more reports of impaired pharmacists in 
the future as a result of this legislation. (46) 
 
Improving identification of impaired HCPs avoids harm to the public and progression of 
the condition. (10) In a 1998 study of opioid addicted doctors, 43% had used drugs for 
more than two years before detection was reported. (16)  
 
According to Centrella in a 1994 review of the available literature on impairment, the first 
barrier to early recognition is a lack of training in recognition. The second was identified 
as the sequential impact of the progression of disease (i.e. family first, work last). Thirdly 
there ensues a barrier of denial in colleagues (the conspiracy of silence) and finally denial 
in the impaired pharmacist. (10) 
 
Whilst more reports are expected with the introduction of mandatory reporting in 
Australia, a major impediment to the effectiveness of mandatory reporting could be the 
first barrier identified by Centrella, that of lack of training in recognition. Mohammad et al 
(2012) in Australia, revealed that mandatory reporting was indeed received with both 
hesitation and apprehension. (47) This emphasised the crucial role of education and 
awareness-raising measures regarding the issue of impairment. Most pharmacists in this 
study expressed a lack of confidence in their knowledge about impairment to enable them 
to identify it in themselves or in their peers. (47)  
 
A 1989 US study of 86 pharmacists recovering from drug and alcohol addictions yielded 
similar findings. Many felt inadequately prepared to recognise or deal with warning signs 
of problems of addiction in themselves or others. (32) Dissemination of information 
relating to the warning signs of drug abuse and sources of help for those affected by 
impairment should be continual goals of any educational program to ensure mandatory 
reporting is effective.  (31) 
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A sequential impact of the progression of the condition has been recognised and is a 
significant barrier to early identification. (10) Obviously impaired clinical skills usually 
indicate an advanced and severe condition. (26) In general, impact upon social and 
personal life usually precedes observed impairment in professional performance. 
Progressive deterioration in all aspects of a person’s life, affecting family, community, 
finances, health, and professional performance is characteristic. (3) Boisaubin et al in 2001 
found that doctors usually strive to delay the impact of impairment upon their career and 
tend to first sacrifice personal life and relations. (26)  
 
The “code of silence” among professional colleagues who hope the problem will resolve 
without their direct intervention was recognised as another barrier that also impedes 
identification. (3) It may result from a lack of understanding of the nature of addiction as a 
condition requiring treatment. (48) The stigma related to implications of impairment and 
being seen as a ‘whistle-blower’ was found to be a deterrent to reporting in Australia in a 
2012 survey study. (47) The majority of respondents expressed reluctance in reporting 
impairment due to concerns for job security, impact on relationships, feeling it was beyond 
their scope of responsibility and fear of punitive responses to reports. Reporting to the 
pharmacy regulatory body AHPRA (Australian Health Practitioner Regulation Agency) 
was only a last resort. (47) Accurate reporting of the prevalence of substance misuse in 
HCPs is often undermined by colleagues either protecting or ignoring the impaired 
individual, and by treating doctors often anxious to avoid ‘labelling’ a colleague with a 
potentially damaging diagnosis. (13) Colleagues and staff members may be reluctant to 
report their suspicions, fearing intimidation, occupational and financial reprisals, or the 
need to protect the business. (3) Even patients may have a barrier to reporting. The 
accepted view is that the HCP takes care of the patient and not vice versa. Both 
pharmacists and patients may view the pharmacist as being “immune” to developing 
substance use disorder. (3) 
 
Denial in the impaired pharmacist and the fear of stigmatisation are major barriers to self-
reporting. (10) The fear of being stigmatised, and apprehension regarding the inevitable 
souring of relationships with colleagues was found to be a barrier to Australian 
pharmacists’ self-reporting. (47) In the US, a study revealed there is the perceived and 
often real issue of professional, societal, and even legal sanctions. Promised guarantees of 
confidentiality and a non-punitive response do not overcome the very real threat of 
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sanctions and job termination. (26)  
 
Stigmatised HCPs can suffer ostracism from the mainstream profession. (5) A qualitative 
study in 1998 of nurses labeled “impaired” by the profession identified themes such as: 
living with a negative label, denial of employment, and inability to share one's recovery 
with professional peers. (5) The medical model approach defines substance abuse as a 
condition amenable to treatment and not a moral weakness or criminal behaviour. (23) 
Education in line with this approach has been recommended and can remove ‘stigma’ as an 
impediment to reporting and prevent impaired HCPs suffering ostracism. 
 
1.7 Prevention 
While there is widespread recognition of the need for education for prevention, there is 
little research assessing the adequacy of such prevention programs. Wright (1990) 
criticised the medical profession for merely attempting to provide “more” substance-abuse 
education without questioning the type of education being provided. (24) There is little 
quantitative and methodologically valid guidance on what constitutes an adequate 
intervention. (30) According to Baldisseri’s systematic review of the literature on 
impairment in 2007, the effectiveness of medical education in preventing later 
dependencies has never been studied. (3) 
 
The medical model approach to the impairment problem is limited in regards to education 
and prevention issues. (49) Contributing social or environmental influences may be 
downplayed when viewing drug use as a condition. (50) According to Hollinger et al 
(2002) insufficient attention is given to professional or occupational socialisation processes 
such as occupational stress and ready drug access that contribute to the problem.  
Inherent to prevention program design would be recognition of the ready availability of 
drugs, professional definitions concerning drug use, and the influence of interpersonal 
associations on drug-using behaviour. (50) 
 
The pharmacy profession needs to focus on the establishment and perpetuation of ethical 
norms that govern acceptable attitudes and behaviours, such as self-medication, in the 
workplace. (23) Several studies such as the study by Dabney et al in 1996 have linked 
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work group influences to the occurrence of deviant behaviour-including theft and use of 
medications in pharmacy. (23)  
 
It has been recommended that prevention can occur before the development of impairment 
using screening to identify ‘at risk’ students and by utilising primary prevention. (49) 
Primary prevention programs seek to prevent impairment by promoting wellness, for 
example drug education and well-being committees. (49) Prevention can also occur in the 
early stages of impairment with secondary prevention programs that target those showing 
early signs of impairment, such as counselling programs. Tertiary prevention programs 
prevent relapse by helping recovering addicts achieve and maintain drug-free lifestyles at 
the rehabilitation stage. (49) 
 
While more education about the matter of impairment is clearly required, it is not yet 
widespread. A 1998 survey by Coombs et al of universities in the US, revealed that tertiary 
prevention programs to help recovering addicts achieve and maintain drug-free lifestyles 
were well developed in all 50 states. The survey found that secondary prevention programs 
for early detection and counselling existed, but were not widespread. Educational 
institutions offering primary prevention programs such as drug education, stress reduction, 
or health enhancement were found to be lacking. This reveals the problem is rarely 
addressed before the symptoms become blatant. (49) 
 
1.7.1 Screening 
As mentioned, it has been suggested there may be a role for screening tests at the 
University level as a prevention tool. (51) In line with this suggestion, the University of 
South Carolina requires its first year medical students to anonymously complete two tests 
to assess their risk for substance dependency. (49)  
The first, the Michigan Alcohol Screening Test, detects alcohol abuse. The second, the 
Children of Alcoholics Screening Test, measures a wide array of behavioral, emotional, 
and psychosomatic dysfunctions. A study by Johnson et al in 1990 revealed that these 
screening tests were a successful intervention, with the majority of first year medical 
students who were rated as having a ‘serious risk’ of alcohol abuse seeking therapy. (51) 
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1.7.2 Primary prevention 
There is evidence that primary prevention programs can be effective, as a 1988 student 
study in Canadian and US Universities revealed. (52) Encouraging students to attend to 
their own health habits resulted in improved preventive health behaviors, attitudes, and 
knowledge, compared to a control group. Most students improved in general health and in 
coping effectiveness. They also studied more outside class, enjoyed school more and felt 
more competent. Program components included an orientation day, aerobic classes, time 
management, nutrition classes, support groups, and relaxation/meditation training. (52) 
 
1.7.3 Secondary prevention 
Educational facilities are recognising the need to provide secondary and tertiary prevention 
programs. The American Association for Colleges of Pharmacies Special Interest Group 
on Student and Faculty Impairment recommended the following policy guidelines in 1990: 
“Recognise impairment as a disease and accept responsibility to identify and facilitate the 
education and potential recovery of chemically impaired students and their immediate 
families.” (49)  
 
A confrontational approach using interventions, behavioural contracts, and monitoring is 
also utilised at a number of medical schools in the US. They have various names but the 
first was AIMS (Aid to Impaired Medical Students), which began in 1982 at the University 
of Tennessee. (49) This program’s general objective was to provide confidential assistance 
ensuring no penalty or stigma in order to protect impaired students and their patients from 
harm. By highlighting that impairment potentially ruins physical and emotional health and 
damages careers, students are encouraged to show concern by identifying and assisting 
impaired classmates. The obligation of students to report an impaired classmate was 
emphasised. (49) 
 
1.7.4 Tertiary prevention/treatment internationally 
Tertiary prevention programs were found to be far more developed. Literature (53-55) 
suggests that most governing pharmacy bodies in developed countries have adopted a 
rehabilitation philosophy that emphasises the following six conceptual elements: (23)  
1) Identification  
2) Evaluation  
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3) Intervention  
4) Treatment  
5) Recovery   
6) Re-entry 
Mounting evidence that substance abuse is best approached as a primary illness/condition 
rather than a moral problem has changed the orientation from punishment to treatment. 
The medical model orientation towards impairment is predominant in the US since 1987 
when the National Association of Boards of Pharmacy issued a policy statement that 
emphasised the medical model of addiction focusing on treatment. (23) 
 
 In 1982 Morrow noted that the medical model approach requires “an emphatic posture 
that minimises the moral condemnation and stigmatisation of the offender, a humanitarian 
commitment to rehabilitation, rather than punishment...”(48) Subsequently the 2001 the 
Joint Commission on Accreditation of Healthcare Organisations standards state: “The 
purpose of the process is assistance and rehabilitation rather than discipline, to aid a 
healthcare professional in retaining optimal professional functioning, consistent with 
protection of patients.” (3) 
 
This empathetic posture has been adopted in US pharmacy. The recovery programs stress 
that impaired pharmacists should not be morally censured, as the individuals’ actions are 
the result of their uncontrollable impairment. Employers, accreditation agencies, and state 
boards of pharmacy endorse and cooperate in confidential recovery programs aimed at job 
re-entry. (23) Building upon earlier pioneering work by US doctors, the American 
Pharmacists Association acknowledged that substance abuse was an issue within the 
profession and has worked to adopt and institute policies of treatment, prevention, and 
rehabilitation. (31) Some states have also included the treatment of mental illnesses 
including sexual abuse disorders. (3) 
 
Treatment goals of impairment due to substance abuse include; understanding and 
acceptance of disorder, identification and recognition of triggers that prompt abuse, 
development of the necessary emotional and behavioural coping skills, and lastly, 
continued abstinence. (56) Multiple modalities have been employed as rehabilitation 
techniques. These include psychotherapy sessions, 12-step programs, and alternative 
therapies, such as meditation, yoga, and relaxation training. (3) 
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In 1982 the first program run by the Texas Pharmaceutical Association was designed to 
“provide assistance to impaired pharmacists and pharmacy students as well as their 
families, friends, customers and coworkers”. The program adopted the 6-step rehabilitation 
philosophy to assist in obtaining evaluation and treatment for their condition. It has since 
changed its name to the Pharmacist Recovery Network (PRN) and expanded nationwide. 
(3) Participation in the program is voluntary; federal and state confidentiality laws apply to 
all participants. The majority of treatment programs function with a multidisciplinary staff 
that can include a psychiatrist, a social worker, and a psychologist, as well as those trained 
in medication addiction. (57) Some of those working in the PRN programs are in recovery 
themselves. Reporting can be made directly to PRN by means of a 24-hour, toll-free 
hotline. Funding comes from drug manufacturers, individuals, member associations, 
pharmacies, wholesalers, and the State Boards of Pharmacy. (57) The program offers 
services which include; educational presentations, advice concerning actions related to 
chemically dependent pharmacists, intervention planning, assistance in conducting 
interventions, chemical dependency assessment, a monitoring contract, referrals to 
appropriate treatment programs, periodic contact with an assigned sponsor, urine drug 
screens, and a written report of compliance of contract to appropriate individuals. They 
hold intensive seminars to attract leaders and researchers to the issue of impairment. After 
treatment, the Committee on Pharmacists Rehabilitation aids the pharmacist or student in 
re-entering the profession or returning to university. (57) Recovering HCPs may need 
assistance updating skills and may need assistance if they encounter the bias of workplaces 
and colleagues when re-entering practice. (3) 
 
A 12-step program is a self-help or support group comprised of people who share the same 
addiction or compulsion, the most renowned being Alcoholics Anonymous. (3) A 12-step 
support group specifically for pharmacists known as International Pharmacists Anonymous 
(IPA) was developed in 1988 in the US. This peer support self-help organisation quickly 
grew in membership and represents a supportive group of pharmacists who use their shared 
experiences to reinforce and maintain a state of sobriety. Membership is free. (23) 
 
In the United Kingdom (UK), there are a variety of support programs for those in the 
pharmacy profession. Pharmacist Support began as the Benevolent fund in 1963 and was 
renamed in 2008. It provides programs to assist those in the pharmacy profession and their 
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families in difficult circumstances. (58) Its Health Support Programme assists pharmacists 
with substance use disorder issues, providing ongoing support through a network of self-
help groups. (59) It also provides a Listening Friends Scheme that provided support to 
1,000 pharmacist, pharmacy student and trainee members in the 1995-2002 period. It 
offers a confidential telephone counselling service for pharmacists in stress that may be 
due to work or personal reasons. (58, 60) 
 
The National Clinical Assessment Service (NCAS) is also available in the UK and was 
established in 2001. (61) It provides case management services to health care organisations 
and to individual doctors, dentists and pharmacists. NCAS offers a wide range of 
confidential services relating to skills, behaviour and health, targeted to help practitioners 
return to safe practice. (61) 
 
Similarly Canada’s Professionals Help Program (PHP) offers help to impaired pharmacists 
with an empathetic approach; from the presentation of a problem, through a process of 
assisting a pharmacist with a referral to a treatment resource, as well as supporting, 
monitoring and advocating for a pharmacist after treatment. (62) The PHP also provides 
details of their more intensive resources, such as intervention support. The PHP clearly 
outline their confidentiality policy, stating that at no time does the Ontario Pharmacists’ 
Association or the Ontario College of Pharmacists receive information about individuals. 
(62) 
  
1.7.5 Prognosis 
Many of these programs have documented high success rates. (63) PRN reports success 
rates of up to 85% with a remarkable 81% of impaired pharmacists remaining drug-free 
without relapse. (57) Treatment programs in the US estimate that up to 70% of health care 
professionals successfully return to medical practice. (17, 64) Overall recovery rates for 
impaired HCPs seem to be higher compared with other groups. (3)  
There appeared to be little related literature on the prognosis of impaired pharmacists, but 
there is evidence from other HCPs, particularly physicians, which is helpful.  
Most data show that physicians had better outcomes than the general population, with 
reported abstinence rates of 70% to 90% as revealed by a follow-up study of 100 
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recovering physicians in 1992. (10, 64) Most impaired HCPs have very good skill sets to 
rehabilitate. They tend to be intelligent, strong-willed, and high achievers. (3) Some 
physician programs claimed an overall success rate of 97.5% (for 2 years) in the US in 
1992. (65) The percentage of nurses who reportedly re-enter clinical practice ranged from 
70.2% to 97.4%. (66) Outcomes data reveal that up to 75% of healthcare providers abstain 
for 10 years after treatment.(64) However 15% to 20% relapse within 1–2 years of initial 
treatment. (3, 67)  
In general, there are several good prognostic indicators of re-entry. (10) It was speculated 
that higher recovery rates for HCPs may be because they are highly motivated to abstain. 
This may be because they have much to lose personally, professionally, and financially. (3) 
Two to four weeks of intensive inpatient treatment was associated with good outcomes as 
does subsequent follow-up care. (17) A US study by Domino in 2005 examined 11 years 
of outcome data from the Washington Physicians Health Program. It found that most of the 
healthcare providers who relapsed stopped participating in the recovery programs early. 
(17) In a one-year follow up of New Jersey physicians in 1992, 73.8% of physicians had 
no known relapses and 12.6% had one relapse. Two-year follow up of the same program 
demonstrated a higher recovery rate of 83.8% with no relapses and 13.8% with one 
relapse. (65) Dependent individuals can relapse at any time throughout their recovery 
process, but they are especially prone during the early stages of recovery. Extending the 
follow-up period lessens the likelihood of relapse. (65)  
Although most relapses were observed in the first two years, 13% of relapses occurred 
after the five-year monitoring period, with some identified even nine years later. (17) 
Continuing rehabilitative treatment with weekly outpatient sessions may be necessary for a 
period of two to three years. (65) Ongoing support and advocacy must be solidly built into 
state programs. (17) 
The prognosis is also affected by the patient’s attitude. (64) Prognosis improves if the HCP 
becomes actively involved in the recovery process and accepts that recovery is a lifelong 
process. Emotional acceptance of the need for recovery is paramount to recovery and 
enduring compliance. (3, 26) 
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A peer-support group has proved to be an essential component of the recovery process. 
(64) A 12-step program encourages members to regain control of their lives. The goal is to 
help impaired HCPs regain an optimal professional level of practice. (3) 
 
Monitoring has also been identified as a strongly contributing factor to program success. 
(68) Monitoring methods include frequent contact for behavioural assessment, random 
urine testing with observed micturition, and workplace surveillance. These correlate with 
recovery and continued abstinence. (10, 68) Shore (1987) showed that 96% of physicians 
in Oregon (US) improved when monitored with urinalysis compared with only 64% who 
were not. (69) 
 
Contingency contracting was reported as an effective tool to prevent relapse. (68) In a 
written contract the patient directs the therapist to mail a license-surrendering letter if a 
urine sample contains drug of abuse. The public is reasonably protected, as relapse results 
in license termination. (70) It is well established that drug use behavior changes when the 
reinforcing or punishing contingencies of that behaviour change. (3, 68) Contingency 
contracting resulted in drug use days being reduced 100-fold in one 1986 US study by 
Crowley. (68) Contingency treatments were also useful for securing a drug free period. In 
this time patients can reorganise satisfying and rewarding drug-free relationships and 
activities. However 27% relapsed when the contracts were not in effect. (68) 
 
Involving the family of an impaired HCP in the treatment was usually found essential to 
successful treatment and rehabilitation, and was associated with improved outcomes. (26) 
This was seen from the comparable success rates of Hudolin's method used in Italy, which 
focuses on family involvement and not on inpatient treatment. Arico et al in 1994 observed 
that 78% or 71 of the 91 alcoholics whose families were compliant to Hudolin’s program 
stopped drinking without relapse. (71) The method is based on involving the whole family 
in the on-treatment alcoholic group program. The objective is the modification of the 
family's life-style to utilise self-help and mutual-help strategies. Hudolin’s method also had 
both economic and social advantages for the community, with low cost implementation 
and improved family life. (71) 
 
Factors contributing to poorer outcomes have also been identified in the literature. These 
included legal complications, issues of licensure, and employment issues such as a lack of 
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support from colleagues at work. (26) Denial, self-treatment, occupational success, and a 
certain disdain toward psychiatric illnesses also prevented impaired healthcare providers 
from continuing therapy. (3) 
 
Other factors associated with poor prognosis identified in a 1992 US study by Gallegos et 
al included a failure to understand and accept the illness, continued denial, a dysfunctional 
family, poor mechanisms to cope with stress, overconfidence, poor relationship skills, 
shame, and guilt. This study also found factors such as complacency, self-pity, blame, 
inability to accept feedback, isolation, manipulation, setting unrealistic goals, and not 
attending support group meetings contributed to relapses. (64)  
 
In a retrospective cohort study of 292 US HCPs in 2005, Domino found that HCPs who 
used drugs or alcohol before or during university had higher rates of relapse. (17) The 
study also found that the likelihood of relapse also increased with each relapse. The type of 
drug of addiction also affected the rate of relapse as the study found. The risk of relapse 
almost doubled when a major opioid was the drug of choice compared to all other drugs. 
The estimated cumulative relapse was also comparatively higher (35% compared to 25%) 
when the drug of addiction was an opioid. The risk of relapse also increased in the 
presence of a coexisting psychiatric illness or a family history of substance abuse. The 
presence of more than one of these risk factors further increased the likelihood of relapse. 
(17)  
 
Reintegration into the health care environment should therefore be tailored to individual 
needs and likelihood of relapse assessed. More intense and prolonged monitoring should 
be considered for those at high risk of relapse. (17) Those with dual diagnoses, such as 
substance abuse and depression, need additional treatment. (26) There was a relative 
paucity of data regarding physician recovery from psychiatric diseases in the literature, but 
in general, prognosis and recovery rates are worse than for chemical dependency. (10) 
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1.8 Treatment in Australia  
1.8.1 Treatment and support for other HCPs 
Impairment in the medical and nursing professions in Australia is addressed in line with 
international methods but is still an under-researched domain. (68-73) In New South 
Wales, alcohol, drug problems and psychiatric illness were reportedly the most common 
causes of impairment in doctors referred to the Medical Council in 1998. (16)  
 
The Impaired Registrants Program, or the Health Program, established in 1992 under the 
Health Practitioner Regulation National Law (NSW) enables the Council to deal with 
impaired doctors and medical students in a constructive and non-disciplinary manner, 
while protecting the public. (72) The Program aims for a smooth transition into the 
workforce by providing support. It manages registrants suffering from psychiatric illness, 
problems with substance abuse, and occasionally, physical illness. When a credible 
notification is received, the registrant is assessed by a Council-appointed practitioner to 
determine the extent and nature of their impairment. They then meet with the Council's 
Impaired Registrants Panel. The most common outcome has been conditions on the 
registrant's registration, such as supervised employment, restrictions on possessing and 
prescribing drugs of addiction, attendance for treatment and assessment, urine testing, and 
regular review by the Medical Board. It may be necessary for the registrant to be 
suspended for a period of time. As the registrant demonstrates progress in rehabilitation 
and recovery, the conditions on their registration are gradually relaxed. After a period of 
compliance, doctors may return to full registration. (72) There are no published data on the 
outcomes of these interventions. (16) 
 
Similarly, the Victorian Doctors Health Program (VDHP) provides support to Victoria’s 
impaired doctors. (73) It has a website outlining case studies of impaired doctors and 
detailing their services. VDHP services involve initial assessment and referral to treatment 
provider. The VDHP also provides a Case Management, Aftercare and Monitoring 
Program (CAMP) when ongoing support is required. This involves entering into an 
agreement to comply with a comprehensive range of therapeutic measures, which may 
include primary monitoring by a VDHP clinician, weekly attendance at Caduceus Group 
(exclusively for doctors and medical students), workplace monitoring and chemical 
monitoring. (73) They also facilitate re-entry to the workforce by liaising with employers 
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or colleagues to develop a return to work plan. This may involve a ‘graduated return to 
work’, a ‘back to work conference’ at the workplace and/or the appointment of a 
‘workplace monitor’. For compliant doctors, they may also advocate at the Medical 
Practitioners Board of Victoria, AHPRA, Magistrates’ Courts, hospitals, workplaces, and 
in family situations. For rural doctors they offer a Rural Outreach Program where VDHP 
clinicians go to their area or use the Internet video conferencing as a means of 
communication. (73) 
 
Peer support services are also available to doctors in Australia. The Doctors Health 
Advisory Service DHAS) operates a telephone help line which began in 1982 with the 
support of the Medical Benevolent Association of NSW and the Australian Medical 
Association (AMA) of NSW. (74) It is available in NSW, Queensland and South Australia 
(SA). DHAS is also available in the ACT and Western Australia (WA) where it is referred 
to as the Colleague of First Contact. DHAS caters for doctors, veterinarians and dentists 
and the students of these professions. The help offered is mostly in relation to stress and 
mental illness, drug and alcohol problems, or personal and financial difficulties. DHAS 
also provides health promotion and educational information through their website through 
lectures to interested groups. DHAS offers confidentiality and does not collect any 
identifiable data. (75) DHAS is predominantly a referral service. As soon as a practitioner 
enters into a therapeutic relationship with a treating physician or therapist, the role of the 
DHAS ceases. DHAS is managed by a committee comprising ten doctors, a dentist, a 
veterinarian and a social worker. Almost 30 general practitioners are accredited to answer 
calls and are supported by specialists. (74)  
 
The Doctors Health Advisory Service of Queensland [DHAS(Q)] extends its 24 hour, 
confidential peer support service to help impaired pharmacists and pharmacy students as 
well as doctors and dentists. It has done so since its foundation in 1989. (74) It also 
provides support to their families. It aims to assist practitioners in restoring their full 
personal, professional and social capabilities. The DHAS(Q) helpline offers specialised 
support by trained volunteers. (74) However this support beyond referral is only available 
in Queensland. In other states DHAS provides predominantly a referral service that is 
similar to PSS catering for doctors, veterinarians and dentists only. 
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Doctors in Tasmania and Victoria have access to the AMA Peer Support Service. The 
telephone counselling service offers a point of first contact, a listening ear and referral. 
Privacy and confidentiality are assured.  The service is staffed by volunteer doctors trained 
in counselling and Lifeline accredited. (44) 
 
Victorian nurses have access to the Nursing and Midwifery Health Program (NMHPV), 
established in 2005. (76) The NHMPV is a Victorian Branch ANF (Australian Nursing 
Federation) initiative supported and funded through nurses' and midwives' registration 
fees. The health program runs independently of both the ANF and the Australian Health 
Practitioners Regulation Authority (AHPRA). The program is a discreet, confidential 
support service for nurses, midwives and nursing and midwifery students with impaired 
health, relating to alcohol and drug issues or mental health concerns. Based on the 
successful Victorian Doctors Heath Program, the NMHPV assesses clients and co-
ordinates the required health services, provides ongoing support, reviews treatment, 
provides relapse prevention and monitoring strategies and develops a re-entry to work 
plan, if appropriate. (76) The NHMPV also conducts information seminars at health and 
education facilities outlining the service and how to identify impaired nurses. Current 
discussion of a national program based on this program is ongoing. (76) While nurses do 
not have national programs like doctors in Australia, they have guidelines for the response 
to impaired nurses in the workforce developed in 2001, highlighting the medical model 
approach, which is supported by the international literature. (77)  
 
1.8.2 Treatment and support for pharmacists 
There are no clear guidelines or policies on dealing with impairment in pharmacy in 
Australia. There is no program addressing prevention, treatment and rehabilitation issues 
like those available to doctors and nurses. Impairment is handled by the Australian Health 
Practitioners Regulation Authority (AHPRA) or referred to the National Pharmacy Board 
of Australia. Since 2010, AHPRA is Australia’s integrated regulatory body governing the 
health care professions that were previously divided into 38 National Boards. There are 14 
National Boards including the Pharmacy Board of Australia. These National Boards 
contribute to AHPRA’s costs and AHPRA in turn supports the National Boards in 
implementing the National Registration and Accreditation Scheme. It’s core functions 
include registration, notification and board services. (8) However some states have retained 
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some governing authority such as NSW whereby the Pharmacy Board of Australia may 
convene an Impaired Registrants Panel to assess the case. The system is heavily reliant on 
self-reporting to authorities or complaints from the public notifying authorities. (46)  
 
The implications of impairment can be tremendous and may deter early self-reporting. The 
2009 Pharmacy Tribunal decision in the case of Health Care Complaints Commission 
(HCCC) vs. Larden is an example of this. (78) An impaired pharmacist was found to have 
committed medicine diversion and presentation of fraudulently altered prescriptions for 
drugs of addiction for his own use, over a period spanning 17 years. As a result he was 
deregistered. No possibility of review was given for a full 3 years, despite him pleading 
guilty and being in rehabilitative treatment. (78) The significant financial and career 
related repercussions in this case were clear.  
 
A 2012 survey found that pharmacists’ perceptions of the manner in which the Pharmacy 
handled matters relating to impairment lacked transparency and was a barrier to reporting 
and seeking help. (47) They felt the issue might not remain confidential or an 
inconsiderate/inadequate approach would be taken. Respondents who had suffered or were 
suffering impairment indicated this to be the case. Only a small minority indicated they 
had received adequate support. Participants clearly articulated the need for supportive, 
confidential, non-punitive approaches to promote rehabilitation rather than disciplinary 
measures taken against impaired pharmacists. (47) 
 
There is one support program in Australia for pharmacists. It is limited to residents of 
Victoria, Northern Territory, South Australia and Tasmania. The Pharmacist Support 
Service (PSS) based in Victoria is similar to the UK Listening Friends scheme in terms of 
assistance offered. Independent of the Pharmacy Board, the PSS is a 24-hour confidential 
‘listening ear’ telephone support service rostered by volunteer non-expert pharmacists. (79) 
There may be a good case for expanding this service to Australian pharmacists in all states. 
However there is no study to date on PSS and little is known about the program. This study 
endeavoured to shed light on the PSS function and scope. 
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1.9 Conclusion 
 
Impairment due to mental illness is under-researched and insufficiently addressed 
worldwide. While effective treatment programs for impairment due to substance abuse 
have been established in the US and UK, further efforts are required in the research and 
implementation of prevention and re-entry programs for impaired pharmacists in Australia. 
These would improve early identification through reporting and help overcome barriers to 
re-entry to the workforce. 
 
 Impairment has not yet been comprehensively addressed in the profession of pharmacy in 
Australia, despite programs based on international models for doctors and nurses. It would 
be in the interests of the public and the profession in Australia to have at hand evidence 
based recommendations for a rehabilitative program suitable for implementation 
nationwide. There is a need for profession-specific educational programs about 
impairment, legislation and services available.  
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CHAPTER TWO: METHODS 
 
2 Aim  
A review of the literature highlighted limited research into pharmacist impairment and no 
specific programs addressing the issue in Australia. There is one support program for 
pharmacists based in Victoria, the Pharmacist Support Service (PSS) accessible by 
pharmacists in three states in Australia. The remaining states and territories remain without 
programs. As little is known about the nature of PSS services in the profession and what 
scope of practice PSS functions within, further investigation was needed.  
 
The aim of this study was to explore the role of PSS in addressing impairment in the 
profession of pharmacy. 
 
2.1 Research protocol 
Phase 1 
A short exploratory survey was developed, designed to address the study aim and based on 
the available literature. The survey (Appendix I) was a 21-item instrument which included 
the following types of questions: 
• Dichotomous Yes/No questions to ascertain categorical and personal details 
• Open-ended questions to explore the nature of their service, their training and 
background, their means of recruitment and their insight into the issue of 
pharmacist impairment 
• Likert-type scale items (5 point, with 1 = lowest agreement and 5 = strongest 
agreement) to ascertain level of agreement with proposed assumptions 
 
Hard copies of the de-identified survey, with self-addressed envelopes, were mailed to all 
of the 13 PSS volunteers. 
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Mixed methods were adopted for this study. The data generated from the surveys was 
explored in further depth with follow-up interviews.  
Phase 2 
Semi-structured interviews were conducted with the 10 PSS members consenting to 
follow-up after the survey. The interview protocol (Appendix II) was developed with the 
purpose of enabling the researchers to probe for further detail and depth with respondents, 
regarding the services they provide to pharmacists in need of their assistance and the 
nature of cases presenting to them in the course of their work. 
 
2.2 Research Method   
Mixed method research using a survey or questionnaire and an interview is commonly 
utilised to yield better insight into programs. (80, 81) In the research methods literature, 
survey questionnaires and interviews are seen as having differing and possibly 
complementary strengths and weaknesses. (82) For this reason this combination was 
selected. 
 
In selecting the most appropriate methodology for this research, the following information 
on surveys was considered. Surveys entail several questions that have structured response 
categories and open-ended questions. They have been established as a non-invasive 
effective tool for information gathering, which facilitates research in closely connected 
groups or programs similar to PSS where politically or ethically sensitive topics are 
covered. (83) Surveys have previously been used in similar research in the assessment of 
pharmacy health-promotion programs like PSS (52) and for investigating programs 
addressing impairment in health care professionals. (39)  
 
However, responses to surveys can lack depth. Hence, interviews were selected as the most 
appropriate method to probe for more in-depth information. (84) Qualitative research is 
generally utilised when there is little pre-existing knowledge of the research area, as in the 
case of PSS. (85) It allows the researcher to build a complex, holistic picture, analyse 
words and report detailed views of informants. (86) Qualitative research can be used to 
explore emotions and thought processes that are often difficult to extract (87), yielding in-
depth detail and description. (88) The investigator is able to take an active role, interacting 
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with the participants studied. (89)  
 
Qualitative studies can also be a good means of researching what happens in organisational 
settings. (90) They can be used to understand programs or services (91, 92) and have 
facilitated the exploration of other volunteer groups like PSS (93); and more specifically, 
in assessing impaired healthcare professional programs. (94) For this reason, a qualitative 
approach was selected to facilitate the exploration of the PSS program. 
Interviews are the most widely employed method in qualitative research (95) and are long 
established as a useful tool in pharmacy program research (32, 96) They are particularly  
useful for pursuing in-depth information around a topic (86) and enhance data quality with 
more details, yielding rich, in-depth data. (83, 88)  
 
Interviews have been used in health research to identify issues and give insight into 
people’s experiences, perceptions, opinions, feelings and knowledge. (88) They afford the 
interviewer the ability to experience the affective as well as cognitive aspects of responses. 
(89) Some survey responses lacked the desired in-depth information and insight and were 
thus supported by further interviews. In this study, interviews were utilised to more 
thoroughly capture PSS volunteers’ feelings and opinions. 
 
In selecting the most appropriate type of interview, the following advantages of the semi-
structured interview were considered. This involves the use of an interview protocol, or a 
list of questions or fairly specific topics to be covered. (95) However, questions may 
deviate from the outlined schedule to further investigate comments of interviewees 
allowing the interviewee a great deal of freedom in their responses. (83) Interviewers can 
also explore interesting or unexpected ideas or themes raised by participants. (86) This can 
yield new insights. This was necessary as the research into PSS was exploratory and 
conducted without any previous theories. 
 
Semi-structured interviews also allow the participant to describe in their own words what 
is meaningful or important to them without being restricted to predetermined categories; 
thus participants may feel more relaxed and candid. This was necessary in exploring a 
closely connected group like PSS that values privacy. Furthermore, data quality is 
enhanced by ensuring that participants are interpreting questions the way they were 
intended. The interviewer is able to explain or help clarify questions, increasing the 
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likelihood of useful responses. (83, 88)  
 
Thus, using a qualitative semi-structured interview methodology, along with an 
exploratory survey, allowed the researchers to explore PSS volunteers’ role in addressing 
the issue of pharmacist impairment. 
2.2.1 Research governance  
This study was approved by the Human Research Ethics Committee at the University of 
Sydney. (Appendix III) 
 
2.3 Data management 
2.3.1 Data collection 
Data collection for the surveys was carried out from October to December 2011. Hard 
copies of the de-identified survey returned in the self-addressed envelopes provided were 
collected. Data collection for interviews was carried out from May 2012 to October 19th 
2012 by telephone. The interview length ranged from 5-55 minutes. On average, the 
interviews were 20 minutes in length. All interviews were conducted by the same 
interviewer to ensure consistency between interviews.   
 
The confidentiality of the volunteer’s identity was assured and consent to audiotape-record 
the interview was granted. Volunteers were informed that they may stop the recording or 
the interview at any time. However there were no instances of this occurring during the 
course of data collection. 
 
2.3.2 Data processing 
The survey data was analysed separating demographic data and quantifiable answers from 
responses to open-ended questions. The audiotape-records of interviews were then 
transcribed verbatim in English, and qualitatively analysed.  
 
2.3.3 Data Analysis 
The analysis of interview transcripts and survey responses to open-ended questions was 
based on an inductive approach, identifying patterns in the data using thematic codes. The 
themes were identified and developed throughout the data collection and the analysis 
process. (87) This sequential analysis had the advantage of allowing researchers to refine 
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questions, develop hypotheses and pursue emerging avenues of interest in greater depth. 
(97) Thus, the analysed data shaped the ongoing data collection.  
 
The themes identified emerged from the data rather than being imposed on the data prior to 
data collection and analysis. (88) These themes were categorised and conversational 
excerpts that illustrated the given thematic category were organised under these categories 
with the assistance of NVIVO Version 8 (2008).  
 
Data were analysed inductively using the constant comparative method (87, 98) whereby 
segments of the transcribed interviews and surveys were reviewed to decide what thematic 
category fit the concepts suggested by the data.  
 
Themes gradually emerged as a result of a three-level process of 1) becoming intimate 
with the data, 2) making logical associations with the interview questions, and 3) 
considering what was learned during the initial review of the literature. At successive 
stages, themes moved from a low level of abstraction to become major, overarching 
themes based on evidence provided by the data. These emerging themes became the major 
findings of the study. 
 
2.4 Study limitations 
 
An inherent limitation to the study was the small group sample of 13 total PSS members. 
Like all methods of data collection, surveys and interviews have certain limitations and 
were addressed by the researchers. 
 
While survey questionnaires are viewed as a more objective research tool, results can be 
affected by many factors (82) including: inadequate questionnaire design; sampling and 
non-response errors; biased design and phrasing; respondent unreliability, ignorance, 
misunderstanding, reticence, or bias; errors in coding, processing, and statistical analysis; 
and faulty interpretation of results. (99)  
 
Whilst the survey was not a validated instrument and hence not absolutely reliable or able 
to be duplicated for re-use, it facilitated the exploration of PSS. The formulated questions 
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were based on the literature with particular focus on gaps in the literature. To minimise the 
survey limitations, the following steps were taken in selecting survey questions. (1) The 
questions were pre-examined vigorously for bias, sequence, clarity and face-validity; (2) 
Follow-up with interviews was undertaken to further clarify non-responses, 
misinterpretation of questions and to yield detail where responses were detached or 
insufficient. 
 
Questionnaire research can also be seen as over-reliant on instruments (82) and, thus, 
disconnected from reality, the measurement processes create an artificial sense of 
accuracy. (100) However, semi-structured interviews provide high credibility and face 
validity and the results make intuitive sense to participants and to lay audiences. (83, 88) 
Thus, this survey limitation was addressed by the strength of the interview. 
 
Interviews are also not neutral tools; data are based on personal interactions that can lead 
to negotiated and contextually based results. (101, 102) The interviewer can use 
questioning to lead or manipulate interviewee responses. Due to the interpersonal nature of 
the interview context, participants may be more likely to respond in ways they deem 
socially desirable, rather than what they really believe. (82) Issues relating to self-reporting 
also affect both surveys and interviews. (82) Studies have found that people can 
simultaneously hold conflicting conceptions and beliefs (103, 104) which may cause them 
to respond in seemingly contradictory or inconsistent ways. Additionally, poor or 
incomplete memory of events, external influences, and lack of time to fully recall 
information may lead to purposefully or accidentally inaccurate recall and response. (105) 
Thus the interviewees may distort information through recall error, selective perceptions 
and a desire to please the interviewer (106, 107) 
 
The following steps were taken by the interviewer during interviews to minimise these 
limitations associated with semi-structured interviews. (1) The questions were examined 
vigorously for bias, sequence, clarity and face-validity; (2) ample time was given for 
responses and the interviewer gave encouragement to think responses through before 
responding; and (3) and the interviewer made a conscious effort not to limit, influence or 
control the volunteer’s responses.  
 
Qualitative interviews have also been criticised as being more subjective than quantitative 
	   	   	  
	  	   	   31	  
interviews because the researcher decides which quotes or specific examples to report. (82) 
Researchers’ subjectivities can influence the process of inductive coding. (100) It can also 
be difficult to judge whether proposed qualitative categorisations actually suit the data as 
normally only small excerpts are presented in manuscripts. 
 
To address these limitations peer debriefing, reflexivity, and triangulation were employed 
in this study to enhance validity (108) and ensure the collected data accurately represented 
the phenomenon being studied. (95) Peer debriefing involved regular meetings with 
knowledgeable peers not directly involved in the research. Reflexivity involved self-
awareness and critical self-reflection by the researcher to assess possible bias and 
predispositions that may affect the research process and conclusions. The method of 
triangulation, or verifying facts through multiple data sources of survey and interview 
combined was used. Member responses to the same questions in surveys and interviews 
were examined for homogeneity. Through these measures, the monitoring or control of 
potential bias was enabled. 
 
Furthermore, two or more researchers reviewed the interview protocol questions 
independently to improve content validity (109) and inter-rater reliability. At the 
completion of each interview, the researcher and supervisor discussed the issues that 
surfaced to ensure coherence. To effectively reduce bias, the data were reviewed 
independently and emerging themes discussed by the researchers until consensus was 
reached. (97, 110) Disagreements amongst researchers stimulated further discussion and 
resulted in deeper insight. This improved the quality of the research. 
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CHAPTER THREE: RESULTS   
3 Introduction 
This chapter presents the results of the survey responses and interviews conducted with the 
Pharmacist Support Service (PSS) volunteers. It provides a description of the volunteer 
sample and reports on the surveys and interviews. This latter section is classified according 
to the key themes derived from the analysis of these responses. 
 
3.1 Survey Results 
Of the 13 PSS members, 11 responded, giving a response rate of 85%.  
 
3.1.1 Sample demographics 
Of the 11 survey participants, the majority were over 50 years old. The majority were also 
female and were practicing pharmacists. The mean years of volunteering experience was 
9.5 years. All PSS members were volunteers. 
 
3.1.2 Level of training 
All the PSS members were trained in crisis counselling, which is an abridged form of the 
counselling training that is provided to Lifeline volunteers. Lifeline is a suicide prevention, 
crisis support and mental health services phone service for Australians. The abridged 
course involved 24 hours of training, achieved in either 8 evenings of 3 hours or 3 full days 
of eight hours. Ongoing training was reported as being provided at regular bi-monthly 
meetings in the form of group discussions, pooling of experiences, role-play and feedback 
from a psychologist. Two volunteers reported having further training in peer support and 
counselling.   
 
3.1.3 Level of commitment 
The study participants reported working on a two-week rotation roster. Each member had 
the PSS phone and the PSS Resource Manual for the duration of their rostered time slot. 
The PSS Resource Manual is a compilation of important numbers for referrals, guidelines 
for responding to particular situations and other helpful resources. Some members took 
extra time slots and hence each member was on call for 14-42 days annually. On average 
they reported receiving one-two calls weekly.  
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3.1.4 Motive for volunteering  
Most respondents stated they were motivated to volunteer through a belief that their 
service was either essential or very important to the profession and the public. Several 
reported being motivated by a desire to “give something back” to the profession of 
pharmacy. 
The majority believed that the service should remain as a volunteer service. However, 
several participants held the opinion that if the service grew, there would be a necessity for 
at least one paid position. 
 
3.1.5 Method of recruitment 
Most respondents became involved in PSS through their involvement in the Victorian 
Pharmaceutical Society of Australia which hosts some PSS lectures and contains a PSS 
link with a brief description on their website. Two were recruited by existing PSS 
volunteers and one member was recruited through seeing a public advertisement calling for 
volunteers. 
 
3.2 The nature of calls made to PSS   
The nature of calls were diverse, reported to range from work-related to personal types of 
enquiries. The type of calls and examples clustered in the following manner: 
3.2.1 Trauma 
A common work-related issue that resulted in calls to PSS was due to trauma.  
This resulted for example, from: 
• Holdups  
• Death in pharmacy 
“Some people after a holdup feel like they don’t need help. They do. I 
help them realize that fact and get access to the help they need.” 
(Survey 1) 
 
“A young male pharmacist was stabbed in the chest while working in 
the pharmacy. He called us for counselling and advice on how to handle 
the situation” (Survey 4) 
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3.2.2 Legal Issues 
PSS received calls about issues of a legal nature that were work-related. For 
example: 
• Dispensing errors (errors occurring whilst processing prescriptions and 
selecting medications) 
“A pharmacist called us about a dispensing error after putting the 
wrong direction on the contraceptive pill and failed contraception could 
result.” (Survey 11) 
 
• Judgement errors 
• Ethical dilemmas 
• Criminal investigations 
“A young female pharmacist was reported by Federal Police to the 
Pharmacy Board, who referred her to PSS. The police officer worried 
she may be suicidal and I learned she was pleading guilty to major 
fraud.” (Survey 4) 
 
3.2.3 The need for information  
PSS volunteers reported receiving calls for a list of contacts. 
3.2.4 Workplace Issues  
Some calls were made to PSS for advice about issues such as: 
• Unacceptable working conditions 
1. Low pay 
2. High workload 
a) Time pressures [e.g. stress of long hours] 
b) Too many prescriptions 
c) Insufficient breaks 
• Less job opportunities 
“Recently, I have noticed an increase in calls about less job 
opportunities.” (Survey 1) 
 
“Most of the calls are about workplace issues, the stress associated with 
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the long hours and the overload of prescriptions.” (Survey 2) 
 
• Employee-Employer Relationships 
a) Intimidation by employers 
b) Insufficient counselling time allowed by employers 
“Young pharmacist callers feel intimidated by employers 
and feel that they cannot practice as taught in University but 
are often too rushed to be able to counsel patients.” (Survey 
4) 
 
3.2.5 Personal Issues 
Calls were also placed for advice on personal issues such as: 
• Divorce 
• Health   
PSS volunteers reported calls received regarding physical and mental 
health (eg substance abuse and mental illness) 
“A caller had to cease work because of a debilitating illness in her mid 
50’s and had to come to terms with the loss of job identity and a feeling 
of not being useful anymore, apart from loss of income.” (Survey 1) 
 
“Substance abuse calls asking to link them up with professional help 
and to make initial contact with the Pharmacy Board.” (Survey 4) 
 
• Family issues  
• Financial problems (business and otherwise) 
“Calls about financial debt are usually only as a result of other 
problems such as gambling or drug use.” (Survey 6) 
 
Support for personal issues as well as work issues was provided as the two were seen as 
inter-related. 
“Personal family problems can impact professional life.” (Survey 1) 
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This was summed up in the open-ended question responses: 
“Because of the nature of their work they cannot function to the necessary level when 
under stress. PSS intervenes in the early stages before a dangerous situation develops and 
helps to mitigate the stress levels. PSS encourages pharmacists to monitor their mental 
and physical well being.” (Survey 6) 
“Not withstanding the work aspect, the pharmacist’s continuing physical and mental 
health is very important. Life can take it’s toll on anyone and a pharmacist is no 
different.” (Survey 5) 
 
 
3.3 The scope of practice 
In responding to these widely varied types of calls, PSS’ scope of practice ranged from 
offering simple advice to active participation in addressing callers’ concerns. PSS 
members engaged in crisis control, advocacy and facilitation of initial contact, listening ear 
(or active listening) and empowerment, as well as offering a referral service. 
3.3.1 Crisis control  
PSS respondents revealed that they used their crisis counselling skills as well as their 
Resource Manual to facilitate crisis control.  
i) Holdups  
E.g. “A young male pharmacist was stabbed in chest while working. He needed 
a locum pharmacist to fill in for him and I was able to organise it. I also 
checked he received counselling with a psychologist after the incident.” 
(Survey 4) 
ii) Pharmacist error resulting in fatal overdose 
E.g. “A young female pharmacist dispensed a fatal overdose and was distressed 
beyond belief. She was referred to PSS by her prescribing specialist who feared 
she was suicidal. I went to see her and organized immediate psychologist 
consultation. I stayed in contact offering support during the investigation.” 
(Survey 6) 
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iii) Death in pharmacy  
E.g. “A very loved elderly customer collapsed at the busy pharmacy counter 
and was taken by ambulance to hospital where he died. Staff continued 
dispensing during this time. Pharmacists and staff were very distressed and 
rang the service. I called the Australian Psychologist Society who arranged for 
the nearest Critical Incident Shock Debriefing Counsellor to go immediately.” 
(Survey 6) 
 
3.3.2 Referral service 
In circumstances where there was no immediate crisis, respondents indicated that they 
often referred callers to required professionals and services. For example 
Rehabilitation services for impaired callers 
“We help substance abuse callers link up with professional help.” (Survey 4) 
Suitable solicitor in legal matters 
Psychologist in social issues, debriefing and counselling 
3.3.3 Advocacy and facilitation of initial contact 
PSS respondents identified one of their most important roles was advocacy for their 
callers. 
“I provide callers with the right contacts to assist them in finding the right solution.” 
(Survey 9) 
Respondents revealed several instances where their advocacy was required and where they 
were able to facilitate initial contact for callers. 
• With the Pharmacy Board regarding impairment and dispensing errors 
“I helped one impaired caller make initial contact with the Pharmacy Board to 
avoid the shame of having their name published in the Board newsletter.” (Survey 
3) 
 
• With PSA (Pharmaceutical Society of Australia)  
“I arranged an initial meeting with PSA personnel to find placement for interns 
who were struggling to find placements.” (Survey 4) 
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• With the Victorian Benevolent Fund 
“I was able to secure financial help for a pharmacist that ceased work due to a 
terminal illness.” (Survey 5) 
 
• With Insurance companies  
“I negotiated with an insurance company to resume lapsed cover which helped an 
impaired pharmacist get free legal advice and treatment.” (Survey 3) 
 
3.3.4 Listening ear and Empowerment 
Respondents noted that they frequently listened and worked through callers’ issues over 
the phone or in person when needed. This was done by providing information from their 
Resource Manual and advice from their personal experience. They helped callers to feel 
empowered by providing a friendly listening ear as a fellow pharmacist.  
“I empower callers by acting as a sounding board to discuss options and help callers 
create a list of ideas and possible actions to address their issues.” (Survey 5) 
 
“I helped callers work through their issues by listening, providing information and passing 
on the experience gained from many years in the profession. I helped them voice their 
concerns to a person who understood their circumstances.” (Survey 3) 
Respondents gave some example case studies of callers they were able to assist in this 
manner. 
“A pharmacist had to cease work because of a debilitating illness in her mid 50’s. She had 
to come to terms with loss of job identity, a feeling of not being useful anymore and from 
loss of income. Lots of calls and conversations followed until she realized she must have 
psychological counselling.” (Survey 1) 
“A young female pharmacist had been working with other female staff until 8pm. She was 
bullied by a drunken man wanting a child sedative and eventually sold it to him. She woke 
at 2am convinced the child was dying of cot death so she rang PSS. I listened, empathised 
and applied logic to reassure the pharmacist, who then thanked me and said she could now 
go to sleep.” (Survey 6) 
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3.4 Interview Results 
Interview responses from 10 of 13 PSS members were obtained. The participants’ 
responses from the interviews were generally found to be consistent with the survey 
responses. 
 
Four themes and corresponding subthemes emerged from the thematic analysis. These 
themes gave insight into the role of PSS and in the investigation of the role of PSS in 
addressing impairment in the pharmacy profession. The main themes identified were; the 
perceived importance of support, limitations of the PSS program, the shortfalls in 
addressing impairment and the implications of mandatory reporting. 
 
3.4.1 Theme 1: The perceived importance of support 
All participants believed the PSS service to be either essential or very important to the 
profession and the public, to prevent crises and to optimise a pharmacist’s ability to 
function. The need to expand nationally to address the support needs of other Australian 
pharmacists outside Tasmania, South Australia and the Northern Territory was also readily 
encouraged. However it was also noted that financial limitations were a barrier to this 
expansion.  
 
3.4.1.1 The perceived importance of PSS to the profession 
All of the participants commented on the importance of their support service for the 
profession. This was not only for the pharmacists themselves but also for the safety of their 
patients. Several participants noted that there is a particular need for support in a 
profession where it is critical to perform optimally.  
 
‘‘Stressed and distressed pharmacists are a liability to themselves, the profession and 
to the public… The likelihood of error is increased in a profession where there is no 
room for error.’ (Survey 6)  
‘ A pharmacist needs to function in a manner not to endanger their clients’ lives and 
well being” (Survey 5) 
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One participant emphasised that the profession of pharmacy is no less in need than other 
health professions such as medicine and nursing, who also have support programs in place. 
 
“The PSS has many similar organisations in the fields of nursing, medicine, dentistry 
and even the general public (Lifeline etc.). It is important that people in crisis or 
needing support have a “one-stop” point of call with no fear of repercussion when 
they don’t know what to do.” (Survey 4) 
 
 
3.4.1.2 The need for national expansion  
Participants unanimously believed there was a need to expand nationally so that all 
Australian pharmacists had access to support. Whilst calls from pharmacists in other states 
were taken, the PSS Resource Manual reportedly does not include any details from states 
not currently affiliated with PSS, making referral services difficult. 
 
“At the moment we are receiving calls from all states, some from the ones we are not 
officially affiliated with but we still take their calls. But it is difficult because we won’t 
have anybody on the ground in the state. We need at least one person that we could call 
upon. And we need details of the resources in every state.”  (Interview 4) 
“I would like to see us expanding PSS so that we can service all Australia.” (Interview 1) 
 
 
3.4.2 Theme 2: Limitations of the PSS program 
Whilst all the participants were satisfied with the level of support PSS provided to callers, 
several limitations to the efficacy of the program were identified. These included financial 
limitations, the inability to initiate follow-up with callers due to privacy regulations, calls 
for further training and concerns that the small volume of calls was due to a lack of 
awareness of PSS within the profession. 
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3.4.2.1 Financial limitations  
Many participants acknowledged financial barriers to expansion of PSS to other states in 
Australia. Some suggested some funding coming from pharmacists’ registration fees as a 
means of addressing this financial barrier. 
 
“We probably could do it right now if we had enough finance to train more volunteers 
to take a higher number of calls, especially if we got NSW.” (Interview 4) 
“Well I would like to see some funding for PSS coming from pharmacists registration 
and I would like to see that money…going toward expanding PSS so that we can 
service all Australia.” (Interview 1) 
 
 
3.4.2.2 Privacy Laws 
Most respondents expressed frustration at their inability to follow-up with callers. 
Australian privacy laws mean that callers cannot be identified and PSS members cannot 
initiate contact with callers unless permission is previously granted. Frustration was due to 
not knowing or being able to further assist in a case. 
 
“At present we don’t get to know what happened to the callers” (Interview 3) 
“It’s really frustrating when you don’t know what happened to callers.” (Interview 4) 
 
Frustration was also due to the lack of feedback, which would be invaluable in assessing 
the adequacy of the support provided and hence being able to improve the support 
program. 
 
“When you don’t hear back, then depending on the type of call, I am sometimes left with 
a feeling that I wish I knew if the contact/information had been of use.” (Interview 1) 
“Unfortunately one of the factors is that there is no follow-up, so I don’t get feedback 
which disappoints me a little bit because I don’t know if I’ve handled the call 
adequately.” (Interview 5) 
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3.4.2.3  Further training required 
Three participants felt that more intense training at the start to equip them for being on-call 
was necessary. Another two volunteers felt either ill-equipped or that further training was 
required to deal specifically with more difficult cases, for example impaired pharmacists, 
requiring follow up support. 
 
“ I consider impairment to be beyond my professional capabilities and my main 
function…So my answer is that I could help them in pointing them in the right 
direction but personally I couldn’t help them.” (Interview 5) 
“I think we do need to set up a more trained and qualified group to meet up with 
people who need ongoing assistance.” (Interview 4) 
 
3.4.2.4  Lack of awareness of PSS  
Participants perceived that the small volume of calls made to PSS reflected a lack of 
awareness of PSS in the profession. They suggested that with better knowledge and 
awareness of the service and the support it provides within the profession, more calls 
would be made. 
 
“I still believe most pharmacists do not understand the service and what help can be 
provided” (Interview 4) 
“Poor awareness of the service is a reason why we don’t receive more calls.” 
(Interview 9) 
“There are some pharmacists who need us and I don’t think we know half of them. If 
they knew there was someone who was actually employed to support them and if they 
were assured of their training, they would probably use us a lot more.” (Interview 6) 
 
3.4.3 Theme 3: Impairment remains unaddressed 
The need to further address impairment was identified as a major issue. All participants 
were unaware or unsure of any programs for impaired pharmacists. They all believed that 
more work was needed in the field of pharmacist impairment. They suggested an 
integrated support program for all impaired health care professionals to enable better 
assistance. Some believed that with adequate funding, PSS could address the issue of 
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impairment by developing links with rehabilitation programs and/or by the provision of a 
website providing information on the matter. 
There was a unanimous call for the improvement in transparency on the issue of 
impairment by AHPRA and the Pharmacy Board. They also called for more education of 
pharmacists on the issue of impairment to remove the stigma associated with it, resulting in 
better reporting and early identification of impaired pharmacists. 
 
3.4.3.1  Impairment support and awareness is lacking 
All participants reported that more work was needed in the field of impairment and that the 
issue was not being sufficiently addressed. They noted that the number of calls they 
received about impairment by no means reflected the real number of pharmacists affected 
by impairment. They came to this conclusion based on peer discussions and personal 
contact with impaired pharmacists. They also drew inferences from the general statistics on 
impairment. They also noted that once reported, impaired pharmacists needed better 
assistance than what they currently receive. One volunteer felt that support mechanisms, 
with the focus on rehabilitation and re-entry into the workforce, were necessary to remove 
the negative view on the issue and lead to empowerment. 
 
“I don’t think impaired pharmacists are reporting to PSS or to the Board.	  Based on 
my own observations and discussions over the years with other pharmacists, there are 
a substantial number of impaired pharmacists who are not reporting.  There’s still a 
problem there which does need to be addressed.” (Interview 3) 
“Given the incidence of drug and alcohol abuse in the community I feel the level of 
reporting of pharmacists is lower than it should be. With mandatory reporting we will 
need to be better able to assist impaired pharmacists.” (Interview 6)  
“At the moment there might be a feeling that ‘Ok well I’m going to be struck off, ‘l’ll 
just give up on my profession’, whereas if there were mechanisms in place they might 
feel empowered to actually go back and work through the process of rehabilitation 
and go back to practice.” (Interview 2) 
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3.4.3.2  An integrated support program  
Whilst most of the participants agreed that improved support mechanisms for impaired 
pharmacists are necessary, some were concerned about the financial viability of a support 
program specifically for impaired pharmacists. They suggested that an integrated support 
program for all impaired health care professionals would alleviate the financial burden on 
the smaller health professions like pharmacy. It was perceived that one advantage of an 
integrated system would be improved participation and outcomes by facilitating a more 
comfortable environment. 
 
“It would make sense to me to make it [support program] across professions. Looking 
at the number of pharmacists which is less than doctors and nurses, we couldn’t 
afford to fund something just for pharmacists.” (Interview 8) 
“If they knew it [support program] was just for HCPs they would feel more 
comfortable…I think that would be great and I wish they did. I think we should pay 
for it out of our registration.” (Interview 6) 
 
3.4.3.3  PSS addressing impairment 
The majority of participants called for increased funding to allow PSS to address 
impairment further. Suggestions for improved support included: online information for 
impaired pharmacists, developing links with specialist rehabilitation centres and further 
training for some volunteers to be able to give ongoing support to impaired pharmacists. 
Two again suggested this could be achieved by imposing a levy on pharmacists’ 
registration fees. Another volunteer held the opinion that government acknowledgment and 
funding was imperative in the long run. 
 
“I’d like to see some funding for PSS enabling us to set up resources for pharmacists, 
perhaps go online to a website and find out information about where they can go for 
specific situations and I’d like to see the Pharmacy Board, again through a levy on 
registration, supporting developing links with other services where we can refer 
people who need specialist help. Referral, particularly for people who have drug and 
alcohol problems, is quite important.” (Interview 1) 
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“The funding should come from peers.” (Interview 9) 
“PSS is there to try to help people but we have limited finances. It costs money and it 
has to eventually be acknowledged and financially supported by governments.” 
(Interview 1) 
 
Furthermore, one volunteer expressed the justification for this financial need by using an 
example showing the relatively higher cost of neglecting the issue. 
 
“I consider that the cost to the community of training a professional, is quite a lot of 
money, so rather than have somebody expelled out of the profession forever because 
they’re not handled correctly, I think would justify some expense in trying to 
rehabilitate them and get them back into their jobs.” (Interview 5) 
 
 
3.4.3.4  Fear of repercussions: transparency needed 
Many participants expressed concern about the fear in the profession associated with 
reporting impairment to AHPRA. They recurrently noted that impaired pharmacists have 
negative views of the post-reporting process. They also noted a lack of transparency and 
clarity surrounding the issue currently. No one seemed to be certain of what happens to 
impaired pharmacists upon reporting. Calls were made by participants for AHPRA to 
provide a clear description of what impaired pharmacists can expect upon reporting. It was 
suggested that providing case studies of impaired pharmacists’ step-by-step return to the 
workforce would remove this fear. 
 
“I think sometimes people have the wrong impression of the Board. They’re scared 
and they think the Board is there to stop them from practicing and [reporting] is 
going to impact their careers. It’s not like that in reality, so I think the Board needs to 
improve their transparency and their communication with the profession. A little bit 
more clarity about exactly what would happen if pharmacists did report themselves to 
the Board… I feel like it’s very “underground” at the moment and if it was a bit more 
out in the open and a bit more advertised, then it might not be so scary for people to 
go and seek help.” (Interview 6) 
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“The issue of mistakes and how they’re handled is not talked about enough through 
AHPRA or the Board, so that there’s not that big stick you’re “going to jail” sort of 
attitude that still hangs over everyone.” (Interview 9) 
“Maybe if that process was more elaborated on by the Board to make people encouraged 
to think ‘Maybe there’s a way out of this and I will not go to hell’, if you know what I 
mean. ‘I’ll be able to take some therapy and be gradually reintroduced back into the 
workforce’ or whatever the conditions were, that might help.” (Interview 1) 
 
3.4.3.5  Stigma associated with impairment 
Several participants noted that there is a definite stigma associated with impairment that 
further impedes seeking help and reporting. One volunteer explained that pharmacists 
assist in the treatment of drug addiction and find it very difficult to define themselves in 
the same category of impairment as their patients. 
 
“..pharmacists are used to dealing with a lot of people who are drug addicts. You 
don’t want to be in that category because you’re used to being on the other side of it 
so there’s a lot of shame.” (Interview 6) 
“There seems to be a great fear of being “named and shamed” that stops people 
seeking help in this case.” (Interview 4) 
 
3.4.4  Theme 4: Implications of Mandatory Reporting 
Participants were asked questions about how they would handle calls relating to 
impairment that legally required reporting to the Board. Only one reported an increase in 
calls relating to impairment since the mandatory reporting requirement enforced in July 
2010. Concerns were raised that mandatory reporting ironically could actually be a barrier 
to reporting. A hesitancy to refer impaired callers to professional assistance was identified. 
It also emerged that volunteers were managing the issue by adopting strategies to avoid 
mandatory reporting. 
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3.4.4.1 Mandatory reporting: A barrier to 
identification 
The majority of the respondents raised concerns that mandatory reporting actually impeded 
reporting. It was thought that impaired pharmacists might be deterred from calling PSS to 
access support as they perceived that PSS members or other professionals, would be 
required to report them. The reasons given for this “fear” of reporting others or self-
reporting impairment, as aforementioned, included fear of the post-reporting processes and 
of the stigma associated with impairment. 
 
“... people are concerned about mandatory reporting…mandatory reporting can have 
a negative impact on people seeking assistance” (Interview 2) 
“mandatory requirement to report impairment… might hold them back from 
reporting to PSS” (Interview 1) 
 
 
3.4.4.2 Hesitancy to refer: A barrier to seeking help 
The PSS service is a confidential service and many of the participants highly valued the 
importance of anonymity to enable the openness required for problem solving. It was 
perceived that this anonymity was also valued by callers. As such, PSS members were 
reportedly hesitant to refer impaired pharmacist callers to health care professionals for 
assistance due to concerns that these professionals would also need to adhere to mandatory 
reporting requirements. The already difficult issue is evidently further complicated by the 
new guidelines. 
 
“It is important for pharmacists to have an anonymous person who can understand 
their situation, to confide in, share their problems with and discuss options and 
outcomes.” (Interview 2) 
 “I think there’s a lot of cover up because of the penalties and I think that mandatory 
reporting has added another dimension to it…I have a problem now with mandatory 
reporting, if I say ‘you have to go to your GP or your psychologist’, because those 
professionals will have to mandatory report them.” (Interview 3) 
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3.4.4.3  Managing mandatory reporting 
Interviewees explained some of the strategies they adopted to manage mandatory 
reporting. Most of the practicing pharmacist volunteers participating in this study 
reportedly evaded the issue of mandatory reporting by offering impaired callers the option 
of a call back from a retired unregistered volunteer. They inform the caller that this person 
has no requirement to report in order to put them at ease.  
“In the PSS because some of us are retired, then the mandatory reporting doesn’t 
really apply to us.” (Interview 3) 
“I’m shortly to retire so it [mandatory reporting] won’t affect me if I’m no longer 
registered. But in the meantime I can get a retired pharmacist to call them back.” 
(Interview 5) 
 
Another strategy to evade the issue was to offer an anonymous service. Some volunteers 
actually warned impaired callers to remain anonymous for their protection.  
 
“One of the reasons why we offer an anonymous service is so people don’t have to 
say who they are and therefore there’s no obligation for our volunteers to report 
them.” (Interview 1) 
“I have to first of all declare early in the piece, tell the caller that we have a policy of 
anonymity except if there’s a life in danger, either to themselves or somebody else. I 
think for the case of impairment it’s very urgent that I get that message through.” 
(Interview 3) 
“Well, that’s why we offer non-identification or anonymity, to avoid these issues.” 
(Interview10) 
 
 
3.5 Overview 
 In summary, the themes that began to surface in the analysis of the survey data were 
further explored in the interviews. The main themes identified were; the perceived 
importance of support, limitations of the PSS program, the shortfalls in addressing 
impairment and the implications of mandatory reporting. These themes gave insight into 
the role of the PSS in addressing impairment in the pharmacy profession. The nature of 
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calls made to PSS were diverse, ranging from work-related to personal types of enquiries. 
In responding to these enquiries, PSS members had a broad scope of practice that included 
crisis control, advocacy and facilitation of initial contact, listening ear and empowerment, 
as well as offering a referral service.  
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CHAPTER FOUR: DISCUSSION AND CONCLUSIONS 
4 Introduction 
The results of this study revealed the role of PSS in addressing impairment to be a listening 
ear and a referral service. Its services are not as advanced as those of similar programs for 
HCPs both within Australia and internationally. PSS is not currently able to address the 
issue of impairment due to financial restrictions and lack of training.  
An integrated program for healthcare professionals (HCPs) may be required as the issue of 
impairment remains unaddressed in the pharmacy profession, which does not enjoy the 
programs that are available to other health professions in Australia.  
Improved awareness of the issue of impairment and transparency on the post-reporting 
process is required to encourage identification of impaired pharmacists. Mandatory 
reporting as a means of identification may ironically be hindering identification. The PSS 
program utilises several measures to avoid mandatory reporting as do support programs for 
other HCPs. (75) 
Despite PSS’ limitations, support for pharmacists is necessary and should thus be available 
to all Australian pharmacists. However, limited finances prevent the national expansion of 
PSS as does lack of awareness of the program. PSS can improve sustainability by 
conducting community awareness campaigns and improving its recruitment techniques to 
attract volunteers to enable expansion.  
4.1 The PSS’ scope of practice 
The scope of practice that PSS functions within involved; crisis control, advocacy and 
facilitation of initial contact, referral service, listening ear and empowerment. This is a 
similar scope of practice as the Doctors Health Advisory Service (DHAS) available in 
several states in Australia. (75) The advice they reportedly give is mostly in relation to 
stress and mental illness, drug and alcohol problems, or personal and financial difficulties. 
Other international pharmacist support services in developed countries such as the UK 
Pharmacist Support also had a similar scope. 
 
The UK Pharmacist Support provides the following services; Listening Friends, Specialist 
Advice Services, Health Support Programme, Grants and Financial Assistance and an 
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Information, Enquiry and Signposting Service. Whilst it has a similar scope of practice to 
the PSS, a greater level of support is offered. Specialist advice services give detailed 
advice on legal issues without referral. The Health Support Programme offers specialised 
intensive care and ongoing support to impaired pharmacists and students, including their 
families and friends. Financial assistance may be offered when the impaired pharmacist 
cannot afford to take time off work for treatment. The Grants and Financial Assistance 
sector actively seeks to secure financial relief for struggling pharmacists and offers a home 
visiting service. (111) 
 
4.2 The importance of support 
Alleviation of stress is important to the provision of optimal health care, avoidance of 
errors, mental health and the prevention of substance abuse. (112, 113) PSS participants 
regarded their support service important for the profession, noting the particular need for 
support in a profession where it is critical to perform optimally. Rethans et al noted that 
influences impacting on health professionals’ performance can be individual-related or 
system-related. Individual-related influences include; physical and mental health, and 
relationships with patients, colleagues, peers, and their own family. System-related 
influences include work environment, patient expectations, guidelines, workload and time. 
(114) PSS endeavours to address all of these concerns, albeit with limited resources. 
In doing so, PSS may also assist in the prevention of impairment due to mental illness. 
Occupational stress or work-related stress is a major cause of mental ill health in 
populations and is a worldwide phenomenon. (115) In the United Kingdom, the recent 
2010 Labour Force Survey estimates an annual incidence rate of work-related stress, 
depression or anxiety of 760 cases per 100,000 workers. (112) 
Similarly, PSS may assist in the prevention of impairment due to substance abuse. Sources 
of risk recognised as precipitators of substance abuse are; general unstructured work 
environment, heightened levels of work related stress, and an absence of social controls. 
(113) It is well documented that the majority of pharmacy practice takes place in 
unsupervised and loose settings marked by high levels of stress. (50, 116) Thus the 
provision of a support service to alleviate and address these issues helps prevent substance 
abuse and in so doing, helps ensure optimal patient care. 
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4.3 Limitations of the PSS program 
Several limitations to the efficacy of the PSS program were identified in this study.  
 
4.3.1 Privacy Laws 
The Australian Privacy Act of 1988 prevents PSS members from initiating contact with 
callers for follow-up unless permission is granted previously. (117) Volunteers reported 
frustration, due to not knowing the outcome or being able to further assist in a case. 
Frustration was also due to the lack of feedback which would be invaluable in assessing 
the adequacy of the support provided and hence being able to improve the support 
program. This issue is legally unavoidable. However the PSS is endeavouring to address 
this issue by conducting regular bi-monthly meetings where they relay information about 
calls they received and obtain feedback on how they handled these calls from the other 
PSS members and a psychologist. 
 
4.3.2 Further training required 
Another limitation to the efficacy of the program was the level of training. More intense 
initial training was called for. All members were trained in the compulsory PSS initial 
Lifeline level of Crisis counselling, which involves 24 hours of training and ongoing 
training at bi-monthly meetings. This level of training is comparable however to that 
undertaken by volunteers of similar programs such as the UK Pharmacist Support service, 
in which volunteers undergo an initial training and selection day in Manchester and two 
residential weekend training courses per year. (111) 
 
Some participants felt either ill-equipped or that further special training was required to 
deal with more difficult cases, for example impaired pharmacists, requiring follow up 
support. This issue may be resolved by an integrated program for impaired healthcare 
professionals. The Doctors Health Advisory Service Queensland [DHAS(Q)] is an 
integrated support program for impaired doctors, dentists, pharmacists and the students of 
these professions. The helpline is staffed by a panel of senior General Practitioners backed 
by specialists experienced in supporting colleagues suffering from health or stress-related 
problems. (74) Expanding this service or introducing a similar integrated service to other 
states would overcome this limitation of lack of expertise and training, allowing PSS to 
remain predominantly a referral service. 
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Further investment in training may improve sustainability of the PSS program. Projects 
with greater training components are more likely to be sustained than those without. Those 
trained can continue to provide benefits, train others and form a constituency in support of 
the program. (118) 
4.3.3 Lack of awareness of PSS  
Some members were concerned that the small volume of calls made to PSS reflected a lack 
of awareness of PSS in the profession and suggested the introduction of a website to 
combat this issue. A lack of knowledge about support services is a common barrier to 
seeking help. Increasing community awareness of a national service initiative or project is 
an essential precursor to program sustainability. (119) The literature overwhelmingly 
shows a positive relationship between community participation and sustainability of 
programs. (119-121) The PSS currently has a one page description of their services and 
contact details on the Pharmaceutical Society of Australia (PSA) website. Not all 
pharmacists are members of the PSA and the PSS would therefore benefit from improving 
awareness of their services within the broader pharmacy community. 
Some effective ways to increase community awareness include: Involving the local media, 
conducting mass mailings, creating a newsletter and creating a website. (122) However 
PSS members noted that funding was a critical barrier to developing a website. 
 
4.3.4 Financial limitations 
The PSS members acknowledged that national expansion was dependent on improved 
funding. Volunteer recruitment may reduce the amount of funding required. Some PSS 
members believed that with adequate funding, PSS could better address the issue of 
impairment. 
 
4.3.4.1 Funding 
PSS members believed there is a need to expand nationally so that all Australian 
pharmacists had access to support. However, they acknowledged the PSS’ financial 
barriers towards expansion. Financing is the most prominent factor in the sustainability of 
programs. (118)  
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Programs in Australia with a similar scope of assistance such as DHAS which provides 
support to doctors, dentists and veterinarians, receive funding from the various 
Registration Boards and Associations of these professions and from donations. (75)  
The Veterinary Practitioners Board of NSW, the Dental Board of NSW, the Australian 
Medical Association (AMA) and the Australian Dental Association all provide financial 
support to DHAS, as do various private medical practices.  
 
Several PSS participants suggested this could be done through a levy on pharmacists’ 
registration. The Nursing and Midwifery Health Program (NHMPV) is an Australian 
Nursing Federation (ANF Victorian Branch) initiative for impaired nurses that is supported 
and funded through nurses' and midwives' registration fees.  
 
Internationally, funding for impaired HCP support programs comes through similar 
channels. Funding for the US Pharmacist Recovery Network (PRN) comes from drug 
manufacturers, individuals, member associations, pharmacies, wholesalers, and the State 
Boards of pharmacy through a levy on registration. (57) UK’s Pharmacist Support obtains 
its funding from pharmacist donations. (111) 
 
4.3.4.2 PSS role in addressing impairment 
PSS members believed they could address pharmacist impairment by developing links with 
rehabilitation programs and by the provision of a website providing information on the 
matter. This would be similar to the level of support for impaired practitioners provided by 
the DHAS (Doctors Health Advisory Service) in several states. (74)  
 
One PSS member expressed the justification for this financial need by using an example 
showing the relatively higher cost of neglecting the issue of impairment. This concern has 
been mirrored in several studies evaluating the cost of substance abuse. The economic cost 
of drug abuse in the US in 2002 was estimated at $180.9 billion. This value represents both 
the use of resources to address health and crime consequences as well as the loss of 
potential productivity from disability, death and withdrawal from the legitimate workforce. 
(33) The latest Australian estimate puts the cost of alcohol-associated problems at $15 
billion. It estimates illicit drugs cost in Australia at about $8 billion. (123) 
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Furthermore, there are losses associated with colleagues not able to re-enter into the 
workforce, such as wasted training, financial losses due to staff turnover and loss of 
contribution to the profession. There was an overall loss from the medical profession in 
NSW of 34% of the doctors who had their drug authorities withdrawn as a result of 
confirmed self-administration of opioids. (16) These losses justify some expense in 
addressing the issue of impairment in the pharmacy profession. 
 
4.3.4.3 Recruitment of volunteers 
In light of the PSS limited funding, expansion to other states would require more 
volunteers and a call for recruitment. Observing general volunteering trends and 
comparing these to PSS volunteering data may help identify groups to target in volunteer 
recruitment that may minimise the amount of funding required.  
In 2006, 34% of the Australian population aged 18 years and over, participated in 
voluntary work. Professionals had the highest volunteer rates, suggesting that the 
pharmacy profession would be a good target for recruitment. (124) 
The PSS has a larger proportion of older volunteers than the general volunteer rates. The 
majority were over 50 years old. (124) As compared with 2006 Australian Voluntary Work 
data, they PSS had more than three times as many employed than retired volunteers, 
significantly higher than the general data trends of 34% for those in full time employment, 
44% for part time and 30% for those who are not in the labour force. (124) PSS may 
benefit from targeting younger pharmacists and retired pharmacists in their recruitment 
endeavours as this seems to be an untapped resource. 
Older PSS members spent more time in voluntary work than younger volunteers which 
also corresponds to Australian volunteer data trends. However retired volunteers did not 
dedicate twice as much time as general volunteers did. (124) PSS may benefit from 
assessing why this may be the case. 
The PSS may benefit from focusing on recruitment techniques to attract volunteers to their 
program for their national expansion. Many community agencies do not have enough 
volunteers to meet their demands. (125) This may limit their expansion and improvement. 
Research into volunteer psychology and motivations can improve recruitment and improve 
the financial viability of programs. (125, 126)  
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An important tool for recruiting volunteers is to assess their motives for volunteering. 
Understanding why individuals are interested in volunteering enables volunteer co-
ordinators to organise their recruitment efforts around themes that are focused on fulfilling 
the specific needs of their target group. (125) There is evidence that matching volunteering 
benefits with personal motivations results in positive volunteer outcomes. For example, 
Clary et al in 1998 found that volunteers who received benefits that matched their 
motivations were more satisfied with their volunteer experience and had greater intentions 
to continue volunteering either at the same or different location in both the immediate and 
long-term future. (127) Thus, it appears that matching motivations with benefits has 
important consequences for recruitment. (126) 
There are six volunteer motives identified by Clary et al (127) in 1998 which include: 
(1) Career - Developing and enhancing one’s career  
(2) Esteem - Enhancing and enriching personal development  
(3) Social - Conforming to the norms of, or establishing norms for, significant 
others  
(4) Protective- Escaping from negative feelings of guilt for being more 
fortunate  
(5) Understanding - Learning new skills and practicing under-utilised abilities  
(6) Value - Expressing values related to altruistic beliefs and helping others  
It was found that the motive rated as most important was the “value” motive, followed by 
the understanding motive and the esteem motive. On average, career, protective, and social 
motives were rated as being less than a moderately important reason for volunteering. 
(127)  
Helping others (value) is the major motive given for volunteering in Australia. (124) This 
was reflected in the PSS volunteer survey data. Most respondents were motivated to 
volunteer through a belief that their service was either essential or very important to the 
profession and the public.  
 
Another major volunteering motivation in Australians reflected in the PSS data, was doing 
something worthwhile. (124) Several volunteers were motivated by a desire to give 
something back to the profession of pharmacy. Thus pitching recruitment efforts around 
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these themes would be suitable for PSS to continue to attract volunteers for their expansion 
to other states. 
 
However, interestingly, no volunteers were motivated by the other major motives for 
volunteering identified in the 2006 Australian Bureau of Statistics data. No volunteers 
mentioned personal satisfaction (esteem) which was the second most common reason for 
being a volunteer. No volunteers mentioned social contact, being active and using 
skills/experience (understanding) or learning new skills and gaining work experience 
(career) which were the other major reasons for being a volunteer. (124) These benefits are 
perhaps not made apparent by the PSS in their recruitment endeavours and the PSS may 
benefit from focusing more on these motives in future. 
 
Some of the volunteers were recruited by either knowing a volunteer or being asked by a 
volunteer which reflects common recruitment pathways as seen in the 2006 Australian 
data. (124) Thus PSS management should encourage members to attract new volunteers. 
 
4.4 Impairment remains unaddressed 
PSS participants reported that more work was needed in the field of impairment and that 
the issue was not being sufficiently addressed. Based on their own experience with 
impaired pharmacists and that of their peers, and the prevalence of impairment in the wider 
community, they noted that the number of calls they received about impairment by no 
means reflected the real number of affected pharmacists. This is reflected in Mohammad et 
al 2012 finding where 21.9% of 370 pharmacists surveyed reported knowing a colleague 
who they thought was unfit to practise. (47) 
 
Mental illness is common in Australia, with one in five Australians experiencing a mental 
illness at some stage in their lives. (9) Mental illness prevalence data on pharmacists is 
lacking. Impairment due to mental illness without concurrent chemical dependency 
accounts for between 6%-20% of cases reported to state physician health programs in the 
US. (10) In a study of a cohort of 261 medical registrants referred to the NSW Medical 
Board because of impairment between l981 and 2001, 40% had a ‘primary impairment’ of 
mental illness, 56% drug and alcohol abuse, and 4% physical illness. (12) However, 
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comorbidity was unreported in this study and there are strong links between substance 
abuse and other mental illnesses. (13) 
 
Whilst there is no study to date examining the prevalence of impairment due to substance 
abuse in the profession of pharmacy in Australia, based on reports in the international 
literature it is estimated that 10% to 15% of all healthcare professionals (HCPs) will 
misuse drugs or alcohol at some time during their career, similar to that of the general 
population. (17)  
 
The number of registered pharmacists in Australia as at 2012 is 26,548. (8) AHPRA 
received a total 378 (1.1% of pharmacists) notifications about pharmacists’ health (14), 
conduct (211) or performance (161) in 2012. It is unclear whether impairment is 
implicated in any of these categories. (8) Therefore the number of notifications clearly do 
not reflect the true number of pharmacists affected by impairment, as noted by PSS 
members. 
 
4.4.1 Impairment support and awareness is lacking 
PSS participants also noted that once reported to AHPRA, impaired pharmacists will need 
better assistance than what they currently receive. There are no clear guidelines or policies 
on dealing with impairment in pharmacy in Australia. There is no pharmacist program 
addressing prevention, treatment and rehabilitation issues like those available to doctors 
and nurses. This may be due to the far lower number of practitioners in the pharmacy 
profession. Whilst there is no national program for impaired doctors or nurses, there are 
programs in the larger states.  
 
NSW Impaired Registrants Program, or the Health Program, established under the Health 
Practitioner Regulation National Law (NSW) enables the NSW Medical Council to deal 
with impaired doctors and medical students in a constructive and non-disciplinary manner, 
while protecting the public. The Program aims for a smooth transition into the workforce 
by providing support. (72) 
 
Similarly, the Victorian Doctors Health Program (VDHP) provides support to Victoria’s 
impaired doctors. It has a website outlining case studies of impaired doctors and detailing 
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their services. (73) Their services involve initial assessment and referral to treatment 
provider. They also provide a Case Management, Aftercare and Monitoring Program 
(CAMP) when ongoing support is required. This involves entering into an agreement to 
comply with a comprehensive range of therapeutic measures, which may include primary 
monitoring by a VDHP clinician, weekly attendance at Caduceus Group (exclusively for 
doctors and medical students), workplace monitoring and chemical monitoring. They also 
facilitate re-entry to the workforce by liaising with employers or colleagues to develop a 
return to work plan. This may involve a ‘graduated return to work’, a ‘back to work 
conference’ at the workplace and/or the appointment of a ‘workplace monitor’.  
The VDHP may also advocate for compliant doctors at the Medical Practitioners Board of 
Victoria, AHPRA, Magistrates’ Courts, hospitals, workplaces, and in family situations. For 
rural doctors they offer a Rural Outreach Program where VDHP clinicians go to their area 
or use the Internet as an audio-visual means of communication. (73) 
 
Based on this program, Victorian nurses have had access to the Nursing and Midwifery 
Health Program (NMHPV) since 2005. The NMHPV assesses clients and co-ordinates the 
required health services, provides ongoing support, reviews treatment, provides relapse 
prevention and monitoring strategies and develops a re-entry to work plan. Like the 
VDHP, the NHMPV also conducts information seminars at health and education facilities 
outlining the service and how to identify impaired nurses. Its website provides a self-
assessment questionnaire that assists impaired nurses recognise they have a problem 
requiring treatment. Current discussion of a national program based on this program is 
ongoing. (76) While nurses in other states do not have national programs like doctors in 
Australia, they have guidelines for the response to impaired nurses in the workforce 
developed in 2001, highlighting the medical model approach which is supported in the 
international literature. (77) 
 
4.4.2 An integrated support program  
Whilst PSS members noted the value of a support program, some were concerned about 
the financial viability of a support program specifically for impaired pharmacists. Stand-
alone or self-contained programs are less likely to be sustained than programs that are well 
integrated with existing systems. (118) Members suggested that an integrated support 
program for all impaired health care professionals would alleviate the financial burden on 
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the smaller health professions like pharmacy and improve the level of assistance offered. 
This suggestion has been utilised outside Australia. Canada’s Ontario Health Professionals 
Assistance Program (OHPAP) is a collaborative program for impaired dentists, physicians, 
pharmacists, nurses, nursing assistants and veterinarians established in 1986. The stimulus 
to its establishment was that individually, it was unlikely that each professional group 
would be able to develop and sustain the types of initiatives required, because of the 
limitations on the availability of expertise and financial support. They noted that although 
some needs and issues were profession-specific, there were others that were common to 
all. (128) 
 
Another example of recognition of the advantages of integrating services to include other 
HCPs occurred recently in the US. The US International Pharmacists Anonymous (IPA), 
established in 1988, decided to "sunset" itself by the end of 2011 in acknowledgement that 
the same services could be offered by another HCP program. Recovering pharmacists were 
thus referred to the International Doctors in Alcoholics Anonymous (IDAA). (57) 
 
The Doctors’ Health Advisory Service Queensland [DHAS(Q)] has also recognised the 
need for an integrated support program for impaired HCPs since its establishment in 1989. 
(74) Supported by the Australian Medical Association (AMA) of Queensland, the 
DHAS(Q) is a 24 hour, confidential peer support service to help impaired doctors, dentists, 
pharmacists and the students of these professions. It also provides support to their families. 
It aims to assist practitioners in restoring their full personal, professional and social 
capabilities. The DHAS(Q) helpline offers specialised support by trained volunteers. (74) 
However this support beyond referral is only available in Queensland. In other states 
DHAS provides predominantly a referral service that is similar to PSS catering for doctors, 
veterinarians and dentists. (75) 
 
As noted by a PSS participant, the advantage of an integrated system would be improved 
participation and outcomes by facilitating a more comfortable environment where patients 
could better relate to each other due to their common ground as HCPs. The advantages of a 
treatment program for peers has been recognised in the US. The Florida Recovery Center 
offers a rehabilitation program for professionals only. The impaired professionals 
treatment centers may include rehabilitation and aftercare. Professional support groups 
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meet at least once a week to address shame, guilt and recovery issues associated with 
addiction. Patients often continue with their groups following discharge, building a 
foundation for long-term support in the professionals recovery community. (129) 
This long-term support of peers can also assist in preventing relapse. Although most 
relapses were observed in the first two years, 13% of relapses occurred after the 5-year 
monitoring period, with some identified even nine years later. (17) Continuing 
rehabilitative treatment with weekly outpatient sessions may be necessary for many years 
after initial treatment. 
 
4.4.3 Fear of repercussions: transparency needed 
PSS participants unanimously called for improvement in transparency on the issue of 
impairment by AHPRA and the Pharmacy Board. They reported that there was fear in the 
profession associated with reporting impairment to AHPRA and that impaired pharmacists 
have negative views of the post-reporting process. Providing case studies or a flowchart of 
what impaired pharmacists can expect upon reporting to remove this fear, was suggested. 
 
A list of signs of impairment and exactly when it should be reported would facilitate early 
identification. Thus improved transparency facilitates secondary prevention which focuses 
on early detection and education. (49) Hence the policy of transparency has been adopted 
internationally in addressing pharmacist impairment. 
 
The issue of impairment is approached with a policy of transparency in the US. The 
Alabama Board of Pharmacy clearly states its approach to impaired pharmacists online 
with a policy of transparency. This policy furthers the mission of the program, which is to 
promote the early identification, intervention, rehabilitation, monitoring and successful re-
entry of recovering pharmacists. It outlines contact details of their Impaired Pharmacist 
Administrator, who can be reached confidentially. They provide clear details on what can 
be expected post-reporting, including offering assistance in preparing for a Board meeting. 
Furthermore, case studies detailing the experience of pharmacists who had reported 
themselves are provided. (130) Similar transparency may be beneficial to improve 
reporting in Australia. 
 
	   	   	  
	  	   	   62	  
4.4.4 Stigma associated with impairment 
PSS participants called for more education on impairment to remove the associated stigma 
that impedes reporting and identification. The stigma related to both being labelled as 
“impaired” and as a “whistle-blower” was found to be a significant deterrent to reporting 
in Australia in a 2011 survey. (47) The majority of respondents expressed reluctance in 
reporting impairment due to concerns for job security, impact on relationships, feeling it 
was beyond their scope of responsibility and fear of punitive responses to reports. 
Reporting to the Pharmacy Board was only as a last resort. (47) This stigma may result 
from a lack of understanding of the nature of addiction as a disease.  
 
The stigma associated with impairment has previously been recognised as a barrier to 
reporting Australian doctors. Accurate reporting of the prevalence of drug misuse in HCPs 
is often undermined by colleagues either protecting or ignoring the impaired individual, 
and by treating doctors often anxious to avoid ‘labelling’ a colleague with a potentially 
damaging diagnosis. (16)  
 
Increasing awareness of impairment using the medical model approach which clearly 
defines it as a disease is required to remove ‘stigma’ as an impediment to reporting. Most 
pharmacists in a recent 2011 Australian survey also expressed a lack of confidence in their 
knowledge about impairment to be able to identify it in themselves or in their peers. (47) 
An older 1989 US study of 86 pharmacists recovering from drug and alcohol addictions 
yielded similar findings. Many felt inadequately prepared to recognise or deal with 
warning signs of problems of addiction in themselves or others. (32) Further training and 
raising of awareness on the issue at the university training level would be of benefit both in 
recognising the need for help in early stages of the condition and to facilitate mandatory 
reporting. It has been recognised in the US that dissemination of information relating to the 
warning signs of drug abuse and sources of help for those affected by impairment should 
be continual goals of any educational program and enables mandatory reporting to be 
effective. (31) 
 
In line with recommendations in the literature, many international pharmacist support 
services have promoted awareness and education in the secondary prevention of substance 
abuse. Ontario’s PHP program is one example. It has fostered and promoted the 
development of clinical services, undergraduate, postgraduate and continuing medical 
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education, research and collaboration with other health professional groups interested in 
and concerned about substance abusing members. (128) 
 
4.5  Implications of Mandatory reporting 
 
PSS members did not report any increase in calls regarding impairment that was expected 
with the 2010 introduction of Mandatory reporting in Australia. The Doctor’s Health 
Advisory Service (DHAS) alarmingly noted a drop in the number of doctors seeking 
treatment since the introduction of the new laws on 1 July 2010. (131)  
 
Mandatory reporting laws stipulate that HCP’s must report colleagues they have adequate 
cause to believe are: 1) not practicing according to the standards,  2) impaired, 3) 
practicing under the influence of drugs or alcohol or 4) guilty of sexual misconduct. (8) 
 
In its second annual report, the national regulator (AHPRA) reported a 40% increase in 
mandatory reporting for HCPs from 2011 to 2012. (8) The number of mandatory reports 
stating a health practitioner had practiced under the influence of drugs and alcohol also 
increased in this interval. However, only five reports related to impaired pharmacists. It 
was not specified whether these were reports of mental illness or physical illness.  
Not one mandatory report related to pharmacists working under the influence of drug or 
alcohol. AHPRA’s 2010/2011 Annual Report did not include this same profession-specific 
information and thus comparison cannot be made between 2012 data and the previous 
report. This low figure of five mandatory reports regarding impairment in 2012 reveals that 
pharmacists are not reporting colleagues they know to be impaired. Mohammad et al’s 
2012 survey of 370 randomly selected Australian pharmacists indicated that 21.9% of 
pharmacists surveyed were aware of a colleague that they thought was unfit to practice. 
(47)  
 
 Whilst 31 mandatory notifications were received from pharmacists in 2012 (pharmacist 
reporting pharmacists and other HCPs), the rate of involvement in notifications was lower 
than those for doctors and nurses, and none reported a colleague pharmacist for working 
under the influence of alcohol and drugs. This may reflect a greater hesitancy towards 
mandatory reporting amongst Australian pharmacists. Mohammad et al in 2012 revealed 
that mandatory reporting was indeed received with both hesitation and apprehension in 
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Australia. (47)  
 
It also remains unclear whether notifications have increased since the introduction of the 
mandatory guidelines in 2010 as the different professions were governed by 38 bodies 
before AHPRA became regulator, making comparison difficult. (8) Thus there is no 
evidence that mandatory reporting has encouraged pharmacists to report their colleague 
pharmacists or that the stigma associated with impairment has lessened since its 
introduction in 2010. 
 
The highest rate of mandatory reports regarding impairment were about medical 
practitioners, and nurses which comprised over 90% of these reports. Pharmacists had 
significantly lower rates of reports. (8) These figures do not reflect the cross healthcare 
comparisons in the literature. Kenna et al’s self report survey study comparing 748 HCPs 
in the US (2004), revealed rates of total illicit drug use by pharmacists was similar to those 
of dentists, nurses and physicians. (15)  
 
4.5.1 Mandatory reporting: A barrier to identification 
As a result of the prevalent ‘fear’ of the post-reporting process due to lack of transparency, 
and of the stigma associated with impairment discussed, PSS members felt that impaired 
pharmacists might be deterred from calling PSS, knowing that the PSS would be required 
to report them to AHPRA. Concerns were thus raised that mandatory reporting actually 
impeded reporting.  
 
These concerns were echoed by the Australian Medical Association (AMA). At the 
introduction of the new laws, fears were raised that mandatory reporting would ironically 
push impaired health practitioners underground rather than assist in their identification. 
(132) Furthermore, concerns were raised that the new laws could have more serious 
implications. The controversial clause influenced the suicide in December 2008 of a 
doctor, who in a note blamed mandatory reporting (in place in NSW at that time) for 
preventing him from turning to colleagues for support or advice. (132) Since then, medico-
legal experts have called for an exemption for doctors treating colleagues, an exemption 
that is in effect in Western Australia only. (133) Adopting a similar exemption for PSS 
members would be expected to encourage impaired pharmacists to seek professional help. 
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 4.5.2 Hesitancy to refer: A barrier to seeking help 
A hesitancy to refer impaired callers towards professional assistance was identified 
amongst PSS participants. The PSS service is a confidential service and many of the 
volunteers highly value the importance of anonymity. As such, many volunteers were 
hesitant to refer impaired pharmacist callers to other (specialist) HCPs for assistance due to 
concerns that these professionals would also have a requirement to report the impaired 
pharmacist to AHPRA. 
 
This hesitancy was mirrored in the recent 2010 national Medical Observer poll of 150 GPs. 
It found that 53% of doctors were less likely to seek help from another GP or advice line as 
a result of mandatory reporting, while just 15% of respondents believed mandatory 
reporting would not negatively affect their decision to seek help or counselling if required. 
(134) The already difficult issue is evidently further complicated by the new requirements. 
 
4.5.3 Managing mandatory reporting 
It also emerged that PSS members were managing the mandatory reporting issue by 
utilising several avoidance measures. They evaded the issue by offering an anonymous 
service, if this was preferred. Before discussing this issue they again warned impaired 
callers not to identify themselves as they had a requirement to report them if they did.  
They further evaded the issue of mandatory reporting by offering impaired callers the 
option of a call back from a retired unregistered volunteer who has no requirement to 
report. 
 
Other Australian support programs also evade the issue of mandatory reporting to 
encourage reporting. The DHAS(Q) promises that they will not report impaired 
practitioners to the respective Boards in any instance. It highlights that it is independent of 
all medical, dental and pharmacy organisations. It notes on its website that extreme caution 
is taken to ensure that any interventions remain confidential and that all mandatory 
reporting concerns are examined thoroughly full prior to a practitioner being approached 
for assistance. (74) However, its volunteers are not excluded from reporting so it is unclear 
how they maintain this confidentiality. (132) DHAS in other states note on their websites 
that they have an obligation to comply with mandatory reporting but that they do not 
collect any identifiable material, to evade the issue. (75) 
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The Nursing and Midwifery Health Program (NMHPV) explains on its website that 
enquiries can be attended to without the requirement of the caller identifying themselves. It 
clearly manages the issue of mandatory reporting by encouraging anonymity. (76) 
 
Outside Australia, Ontario’s PHP considered the complete separation of professional 
supervision and discipline, from assistance and treatment, to be of fundamental 
importance. It thus promises callers complete confidentiality. (62) It is concerning that this 
complete separation has not occurred in Australia, leaving support programs with no 
alternative but to manage the issue of mandatory reporting by several evasion techniques, 
attempting to encourage impaired HCPs to seek help.  
 
4.6 Conclusions 
The aim of this research study was to explore the role of PSS in addressing this issue and 
included an investigation of the nature of PSS services and the scope of practice PSS 
functions within.  
The results of this study revealed the role of PSS in addressing impairment to be 
predominantly a listening ear and referral service. It has a scope of assistance similar to 
other international pharmacists support services in developed countries, but its services are 
not as advanced. This may be due to the smaller number of pharmacists in Australia 
compared to countries such as the UK and US. PSS is not able to handle the issue of 
impairment either financially or in terms of training at this stage. However, with improved 
funding, it can better address the issue by establishing a website and links to rehabilitation 
programs. A website can both promote awareness of the program and the assistance 
provided to ensure better outreach to impaired Australian pharmacists.  
 
While PSS cannot comprehensively address impairment at this stage, it is a support service 
that is necessary for pharmacists to ensure optimal health care for patients and should be 
available to pharmacists in other states. It suffers from several limitations to its efficacy, 
some of which are unavoidable (privacy laws) and others that can be addressed (lack of 
awareness of the program). Its expansion is currently limited due to lack of finances. 
Sustainability issues are often a concern that prevents the continuation and growth of 
programs like PSS. PSS can improve sustainability by conducting community awareness 
campaigns and improved recruitment techniques to attract the necessary volunteers for 
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national expansion. Sustainability can also be improved by imposing a levy on 
pharmacists’ registration as a relatively lower cost than what drug abuse actually costs the 
pharmacy profession in terms of health and crime consequences, as well as the loss of 
potential productivity. 
 
Barriers to improved handling of the issue of impairment include the associated stigma and 
the lack of transparency by AHPRA and the Pharmacy Boards. Better education and 
awareness of the issue is required. Improved clarity and transparency on the post-reporting 
process is also necessary to dispel fears of punitive responses from AHPRA and to 
promote the importance of rehabilitation and re-entry to the workforce. This improved 
transparency would also encourage mandatory reporting and facilitate the early 
identification of impaired pharmacists.  
 
However, mandatory reporting seems to be currently counter-productive. No pharmacist 
reported a colleague for practicing under the influence of drugs and alcohol in 2012 despite 
findings in previous studies that many pharmacists were aware of an impaired colleague. 
(47) The PSS program utilises several measures to avoid mandatory reporting as do 
support programs for other health care professionals. PSS volunteers and other support 
programs such as DHAS are concerned that mandatory reporting may impede impaired 
callers from accessing the help they need. This issue needs to be addressed by AHPRA. 
Promising impunity if a pharmacist has sought and adhered to treatment may decrease the 
‘fear’ of reporting. Better clarity about the process of mandatory reporting including case 
studies, describing exactly what constitutes ‘impairment’ may also decrease this fear. 
Similarly providing case studies of impaired pharmacists that have had successful 
treatment and re-entry to the workforce may also alleviate fears. Allowing support services 
to be exempt from this rule, at least at referral stage, may encourage impaired callers to 
access the services that are available to them. 
 
In light of these findings, an integrated program for all impaired health care professionals 
may be an ideal and sustainable means of assisting impaired pharmacists. One such 
program is already in place in Queensland [DHAS(Q)]. The expansion of such a program 
or the establishment of a similar Australia-wide program would be a major improvement in 
addressing the issue of pharmacist impairment in Australia. The idea of using concerned 
caring peers to intervene on behalf of another peer who is suffering from the disease of 
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chemical dependency has produced great success in the US and today most professional 
societies sponsor a peer-assistance program. (135) Advocacy can be provided for the 
recovering pharmacist. Use of these services can make the difference in saving the 
professional career or possibly the life of a peer (135) and should thus be of major 
importance to pharmacy’s governing bodies. 
 
This research very importantly highlights the need to better address the issue of pharmacist 
impairment. Australian public opinion polls consistently rank pharmacy just below nursing 
as the most honest and ethical occupation. (132) If this issue is not addressed, the 
pharmacy profession may suffer loss of reputation, as well as concerns for patient safety 
and the safety of impaired pharmacists themselves. 
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APPENDIX I-SURVEY 
 
Dr Betty Chaar  
Room N508-Bldg A15 
Faculty of Pharmacy –The University of Sydney NSW 2006 AUSTRALIA 
Telephone: +61 2 90367101 
Email: betty.chaar@sydney.edu.au 
Support for Pharmacists Study 
Information Statement and Survey for PSS Members 
 
Researchers: Dr Betty Chaar, Dr Jane Hanrahan and Dr Carolyn Day [University of Sydney]; Ms 
Kay Dunkley [Pharmacists’ Support Services (PSS), Vic] 
 
Dear PSS Member 
 
We are researchers from the University of Sydney who, along with a representative from 
PSS, are interested in exploring the issue of impairment and fitness to practice in 
pharmacy, particularly in light of the requirements of the new National Pharmacy Act. We 
are sending this survey to you via the PSS in order to retain your privacy in your role as 
PSS member, your details therefore will remain unidentifiable to the research team.   
 
In most states of Australia there has been a panel or an official at the relevant Pharmacy 
Board handling impairment discretely, reliant on self-reporting or complaints from the 
public to notify authorities. This will not continue in the future. It would be in the interests 
of the public and the profession in Australia, now after amalgamation of Pharmacy Acts, 
the introduction of national regulation of pharmacists and the Pharmacy Board of 
Australia, to have at hand evidence based recommendations for a support program 
suitable for implementation across the country. 
 
The aim of this research study is to explore your opinions about and experience with 
impairment in the profession, your role as a PSS volunteer, how and what needs to be 
reported, and how best to address the problem considering the existing programs 
available to other healthcare providers in Australia. 
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We therefore cordially invite you to participate in this short survey to help us acquire some 
insight into your views about this topic.   
 
We estimate that the survey should take no longer than 30 minutes of your time. All 
aspects of the study, including results, will be strictly confidential except as required by 
law and only the researchers will have access to information collected. If you submit a 
completed survey we will assume you have consented to participate voluntarily in the 
study. You may of course withdraw from the survey at any time before submission. 
 
Whilst there will be no direct benefit to you in completing this survey, your participation will 
be very helpful in assisting the profession in addressing this crucial aspect of pharmacy 
practice. This survey is exclusive to PSS members only and is tailored to capture your 
experience and opinions in view of the work you undertake in supporting pharmacists. 
 
If you have any enquiries please contact Dr Betty Chaar (02 90367101).  We would 
greatly appreciate your assistance and contribution to this study. 
  
Thanking you kindly for your time and effort. 
Yours sincerely 
 
Dr Betty Chaar,  
on behalf of the research team Associate Professor Jane Hanrahan, Dr Carolyn Day  ... [The 
University of Sydney] and Ms Kay Dunkley [PSS] 
Any person with concerns or complaints about the conduct of a research study can contact the Manager, Human Ethics 
Administration, University of Sydney on (02) 8627 8176 (Telephone); (02) 8627 7177 (Facsimile) or 
ro.humanethics@sydney.edu.au (Email)
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  THE	  SURVEY	  
	  
Please	  answer	  the	  following	  questions	  
	  
1. How	  long	  have	  you	  been	  a	  volunteer	  with	  PSS?	  	  	  	  	  ................	  	  years	  
	  
2. What	  gender	  are	  you?	  	  	  
¨ Male	  
¨ Female	  
	  
3. What	  age	  group	  do	  you	  belong	  to?	  
¨ 20-­‐30	  
¨ 30-­‐40	  
¨ 40-­‐50	  
¨ >	  50	  (please	  specify)	  ………………………………………………………	  
	  
4. Are	  you	  still	  practising	  pharmacy?	  	  
¨ Yes	  
¨ No	  
¨ Retired	  	  
¨ Never	  worked	  in	  pharmacy	  
	  
5. Have	  you	  had	  any	  training	  in	  the	  field	  of	  support	  for	  professionals?	  
¨ Not	  at	  all	  
¨ Somewhat	  	  
Please	  describe:.......................................................................................	  
¨ Yes	  	  
Please	  describe:.......................................................................................	  
¨ Yes,	  I	  am	  a	  qualified	  expert	  
Please	  describe	  the	  qualification	  
....................................................................	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6. How/why	  did	  you	  become	  involved	  in	  PSS	  work?	  
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………	  
How	  many	  days	  a	  year	  do	  you	  volunteer	  with	  PSS?	  	  ..........................................[estimation]	  
7. How	  many	  calls	  would	  you	  take	  on	  average	  per	  two	  week	  roster?.....................[estimation]	  
8. What	   is	   the	   general	   nature	   of	   the	   calls	   you	   receive?	   E.g.	   mostly	   about	   financial	   debt?	  
Workplace	  problems?	  Impairment?	  Trauma?	  
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………	  
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………	  
	  
9. What	  is	  the	  scope	  of	  assistance	  you	  have	  provided	  over	  the	  years?	  If	  possible	  please	  give	  
unidentifiable	  examples	  to	  help	  describe	  the	  circumstances.	  We	  would	  be	  grateful	  for	  as	  
much	  information	  here	  as	  possible.	  Please	  feel	  free	  to	  use	  as	  many	  pages	  as	  needed	  or	  	  
alternatively	  you	  are	  invited	  to	  phone	  Dr	  Chaar	  on	  02	  90367101	  to	  discuss	  if	  you	  feel	  it	  
more	  appropriate	  to	  talk	  than	  write.	  
[NB:	  Please	  do	  not	  provide	  a	  name	  when	  you	  call,	  simply	  state	  you	  are	  responding	  to	  Q10	  of	  
the	  PSS	  survey.	  Dr	  Chaar	  will	  take	  notes	  from	  the	  phone	  interview	  and	  you	  can	  remain	  
anonymous.]	  
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………	  
…………………………………………………………………………………………………………………………………………………	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10. Do	  you	  believe	  you	  make	  a	  difference	  when	  you	  provide	  support	  to	  a	  pharmacist?	  
¨ No	  
¨ Maybe/	  somewhat	  
¨ Don’t	  know	  –	  I	  never	  get	  feedback	  
¨ Yes	  
If	  you	  answered	  ‘yes’	  to	  this	  question,	  and	  given	  that	  you	  might	  never	  hear	  from	  the	  
pharmacist	  after	  the	  interaction,	  what	  makes	  you	  feel	  you	  make	  a	  difference?	  
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………	  
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………	  
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………	  
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………	  
	  
11. Have	  you	  ever	  been	  in	  a	  situation	  where	  you	  knew	  a	  colleague	  was	  still	  practising	  but	  you	  
thought	  he	  or	  she	  was	  probably	  not	  fit	  to	  practise	  (either	  temporarily	  or	  permanently)?	  	  	  
¨	  Yes	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  No	  
	  
12.	  Were	  you	  able	  to	  take	  action	  in	  that	  situation?	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Yes	  	  	  	  	  	  	  	  	  	  ¨	  No	  
If	  your	  answer	  was	  ‘yes’,	  please	  describe	  this	  action.	  If	  your	  answer	  was	  ‘no’,	  please	  
elaborate	  why.	  
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………	  
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………	  
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………	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13. If	  you	  knew	  the	  pharmacist	  would	  you	  report	  an	  impaired	  colleague	  in	  principle?	  	  	  
a. Yes	  	  	  	  	  	  	  	  	  	  	  	  
b. No	  
14. How	  important	  would	  you	  rate	  your	  work	  supporting	  pharmacists?	  
¨ Of	  little	  importance	  
¨ Somewhat	  important	  (occasional)	  
¨ Don’t	  know	  
¨ Very	  important	  to	  the	  profession	  and	  public	  
¨ Essential	  to	  the	  profession	  and	  public	  
Please	  explain	  why	  
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………	  
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………	  
15. Are	  you	  happy	  with	  the	  level	  of	  support	  you	  offer	  to	  pharmacists?	  	  	  	  	  	  	  	  	  	  	  	  ¨	  Yes	  	  	  	  	  	  	  	  	  	  ¨	  No 
	  
	  
16. Do	  you	  have	  any	  suggestions	  for	  improvement	  of	  the	  support	  system?	  [i.e.	  what	  would	  
you	  like	  to	  see	  in	  the	  future	  in	  this	  field?]	  
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………	  
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………	  
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………	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17. Do	  you	  believe	  this	  kind	  of	  work,	  supporting	  pharmacists,	  should	  be	  remunerated?	  
¨ Not	  at	  all	  
¨ Possibly	  –	  token	  remuneration	  
¨ Not	  sure	  
¨ Remuneration	  is	  important	  
¨ Remuneration	  is	  essential	  for	  expansion	  of	  the	  service	  nationwide	  
Please	  explain	  your	  response:	  
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………	  
…………………………………………………………………………………………………………………………………………………	  
…………………………………………………………………………………………………………………………………………………	  
18. Are	  you	  aware	  of	  any	  programs	  for	  impaired	  pharmacists	  to	  support	  them	  in	  practice?	  	  
a. Yes	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  □	  	  No	  
If	  you	  answered	  ‘yes’,	  please	  provide	  your	  opinion	  about	  any	  other	  program	  that	  might	  be	  
useful	  to	  Australian	  pharmacists	  
……………………………………………………………………………………………………
……………………………………………………………………………………………………
……………………………………………………………………………………………………
…………………………………………………………………………………………………… 
 
19. Do	  you	  believe	  there	  is	  more	  work	  to	  be	  done	  in	  this	  field?	  	  	  	  	  	  	  ¨	  Yes	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  ¨	  No	  
Why?	  
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………	  
…………………………………………………………………………………………………………………………………………………	  
	  
20. What	  in	  your	  opinion	  is	  the	  ideal	  way	  to	  manage	  impairment	  in	  a	  professional,	  bearing	  in	  
mind	  the	  importance	  of	  public	  welfare?	  
……………………………………………………………………………………………………
……………………………………………………………………………………………………
……………………………………………………………………………………………………
…………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………
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Thank	  you	  VERY	  MUCH	  for	  your	  participation.	  	  
Your	  opinions	  are	  valuable	  to	  us.	  
	  
THANK	  YOU	  FOR	  YOUR	  TIME	  AND	  PATIENCE	  
	  
THE	  RESEARCH	  TEAM	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APPENDIX II- SEMI-STRUCTURED INTERVIEW PROTOCOL 
 
1. In your experience, do you think many pharmacists may need access to a PSS 
program or similar in their careers? 
2. Can you give some example case studies of people who got the most benefit from 
your service? 
3. How important do you think your work is to the profession? 
4. Are you able to adequately follow-up a query or call? 
5. Do you think the training you undergo as a volunteer to be sufficient?  
6. Why do you think you don’t receive a high volume of calls? 
7. Do you think PSS is required Australia wide? 
8. What could limit PSS expansion? 
9. Do you think there’s a role for full time paid work as a part of the service? 
10. Where do you think funding should come from? 
11. What do you think of how impaired pharmacists are handled by AHPRA? 
12. Could you recommend any changes to the current system/approach to impairment 
by AHPRA? 
13. Have you received any calls reporting impairment either self-reporting or 
otherwise? 
14. Have you noticed any increase in the number of calls regarding impairment? 
15. How would you handle a call reporting impairment? 
16. Have you heard of programs for impaired pharmacists overseas that you think 
would be suitable in Australia? 
17.  If so, what features of these programs do you find most important? 
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APPENDIX III- HUMAN ETHICS APPROVAL 
 
 
From: Ray Walkinshaw on behalf of Human Ethics  
To: Betty Chaar  
Subject: Annual Report Form Approved (13743) 
Date: Thursday, 19 July 2012 3:01:24 PM 
	  
Dear	  Dr	  Chaar 
Title:	  Support	  Services	  for	  Australian	  Pharmacists	  Protocol	  No:	  
13743	  First	  Approval	  Date:	  16	  May,	  2011 
Thank	  you	  for	  forwarding	  the	  Annual	  Report	  Form	  for	  the	  above	  study.	  
Your	  protocol	  has	  been	  renewed	  to	  31	  May,	  2013. 
Please	  note	  that	  if	  your	  project	  is	  not	  completed	  within	  four	  (4)	  years	  
from	  the	  first	  approval	  date,	  you	  will	  have	  to	  submit	  a	  Modification	  
Form	  requesting	  an	  extension.	  Please	  refer	  to	  the	  guidelines	  on	  
extension	  of	  ethics	  approval	  which	  is	  available	  on	  the	  website	  at:	  
http://sydney.edu.au/research_support/ethics/human/extension. 
Any	  amendments/modifications	  to	  the	  protocol	  must	  be	  approved	  by	  
the	  Human	  Research	  Ethics	  Committee	  (HREC)	  [refer	  to	  the	  website	  at:	  
http://sydney.edu.au/research_support/ethics/human/forms	  for	  a	  
Modification	  Form]. 
Please	  do	  not	  hesitate	  to	  contact	  the	  Research	  Integrity	  (Human	  Ethics)	  
should	  you	  require	  further	  information	  or	  clarification. 
Yours	  sincerely 
Human	  Research	  Ethics	  Committee	  The	  University	  of	  Sydney 
 
